Quiver News
The latest insights and financial news from Quiver Quantitative
Linda R Medler, a director at $PNC, sold 71 shares of the company on 08-27-2025 for an estimated $14,594. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $PNC stock.
$PNC Insider Trading Activity
$PNC insiders have traded $PNC stock on the open market 23 times in the past 6 months. Of those trades, 2 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $PNC stock by insiders over the last 6 months:
- WILLIAM S DEMCHAK (CEO) has made 0 purchases and 18 sales selling 18,630 shares for an estimated $3,161,324.
- E WILLIAM III PARSLEY (Executive Vice President) sold 7,665 shares for an estimated $1,349,040
- KIERAN JOHN FALLON (Executive Vice President) sold 1,492 shares for an estimated $260,443
- MARTIN PFINSGRAFF purchased 1,000 shares for an estimated $158,220
- LINDA R MEDLER sold 71 shares for an estimated $14,594
- MARK WIEDMAN (President) purchased 20 shares for an estimated $3,568
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PNC Hedge Fund Activity
We have seen 813 institutional investors add shares of $PNC stock to their portfolio, and 867 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VIKING GLOBAL INVESTORS LP added 2,375,664 shares (+inf%) to their portfolio in Q2 2025, for an estimated $442,871,282
- WELLINGTON MANAGEMENT GROUP LLP added 1,965,584 shares (+550.9%) to their portfolio in Q2 2025, for an estimated $366,424,169
- AQR CAPITAL MANAGEMENT LLC added 1,917,530 shares (+134.9%) to their portfolio in Q2 2025, for an estimated $357,465,942
- BANK OF NEW YORK MELLON CORP removed 1,429,069 shares (-35.2%) from their portfolio in Q2 2025, for an estimated $266,407,042
- CAPITAL INTERNATIONAL INVESTORS removed 1,247,528 shares (-10.9%) from their portfolio in Q2 2025, for an estimated $232,564,169
- GAMMA INVESTING LLC removed 1,140,649 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $212,639,786
- FMR LLC added 1,109,292 shares (+7.5%) to their portfolio in Q2 2025, for an estimated $206,794,214
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PNC Congressional Stock Trading
Members of Congress have traded $PNC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $PNC stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 03/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$PNC Analyst Ratings
Wall Street analysts have issued reports on $PNC in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 07/30/2025
- Citigroup issued a "Buy" rating on 07/17/2025
- Morgan Stanley issued a "Underweight" rating on 07/17/2025
- B of A Securities issued a "Buy" rating on 07/17/2025
- RBC Capital issued a "Outperform" rating on 04/16/2025
- Barclays issued a "Overweight" rating on 04/16/2025
- JP Morgan issued a "Overweight" rating on 04/03/2025
To track analyst ratings and price targets for $PNC, check out Quiver Quantitative's $PNC forecast page.
$PNC Price Targets
Multiple analysts have issued price targets for $PNC recently. We have seen 14 analysts offer price targets for $PNC in the last 6 months, with a median target of $207.0.
Here are some recent targets:
- Chris Kotowski from Oppenheimer set a target price of $238.0 on 07/30/2025
- Keith Horowitz from Citigroup set a target price of $217.0 on 07/17/2025
- Ebrahim Poonawala from B of A Securities set a target price of $226.0 on 07/17/2025
- Betsy Graseck from Morgan Stanley set a target price of $186.0 on 07/17/2025
- John McDonald from Truist Securities set a target price of $198.0 on 07/09/2025
- David Konrad from Keefe, Bruyette & Woods set a target price of $212.0 on 07/09/2025
- Daniel Tamayo from Raymond James set a target price of $220.0 on 07/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Senator Kevin Cramer and Secretary of the Air Force Dr. Meink visited Vandenberg Space Force Base to review satellite launches.
Quiver AI Summary
U.S. Senator Kevin Cramer and Secretary of the Air Force Dr. Troy Meink visited Vandenberg Space Force Base in California to review 21 satellites from the Space Development Agency's Tranche 1 Transport Layer, which is set to launch on September 10. Cramer remarked on the "impressive work" at the base, emphasizing the importance of resilient space capabilities for national defense.
During the visit, they toured the infrastructure and capabilities of Vandenberg SFB, which supports various space activities for the Air Force, Department of Defense, and NASA. Cramer has advocated for utilizing Grand Forks Air Force Base in North Dakota for upcoming satellite missions.
The visit highlights ongoing advancements in satellite technology and underscores the strategic roles of both Vandenberg and Grand Forks in the U.S. space defense framework. Cramer's efforts include pushing for federal space assets to be directed to North Dakota as part of broader military initiatives.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Kevin Cramer Net Worth
Quiver Quantitative estimates that Kevin Cramer is worth $896.0K, as of August 29th, 2025. This is the 339th highest net worth in Congress, per our live estimates.
Cramer has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Kevin Cramer's net worth on Quiver Quantitative's politician page for Cramer.
Kevin Cramer Bill Proposals
Here are some bills which have recently been proposed by Kevin Cramer:
- S.2326: Payment Choice Act of 2025
- S.2268: Agricultural Risk Review Act of 2025
- S.1868: Critical Access for Veterans Care Act
- S.1828: Safe Routes Improvement Act
- S.1733: Highway Funding Transferability Improvement Act
- S.1716: Vision Lab Choice Act of 2025
You can track bills proposed by Kevin Cramer on Quiver Quantitative's politician page for Cramer.
Kevin Cramer Fundraising
Kevin Cramer recently disclosed $0 of fundraising in a Q2 FEC disclosure filed on July 12th, 2025. This was the 1178th most from all Q2 reports we have seen this year. nan% came from individual donors.
Cramer disclosed $780.0 of spending. This was the 1293rd most from all Q2 reports we have seen from politicians so far this year.
Cramer disclosed $330.9K of cash on hand at the end of the filing period. This was the 558th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Kevin Cramer's fundraising on Quiver Quantitative.
Senator Schmitt introduces the bipartisan ABLE Employment Flexibility Act to enhance savings options for employees with disabilities.
Quiver AI Summary
U.S. Senator Eric Schmitt (R-MO) has introduced the bipartisan ABLE Employment Flexibility Act, aimed at enhancing savings options for employees with disabilities. The legislation will permit employers to contribute to employees' ABLE accounts similarly to 401(k) plans, exempting them from affecting federal benefit eligibility. Schmitt emphasized, "Individuals with disabilities who work deserve the same access to employment benefits."
The bill addresses the barriers faced by employees with disabilities regarding 401(k) benefits due to stringent asset limits of federal programs like Medicaid and SSI. It is supported by Senators Amy Klobuchar (D-MN) and others, and follows the earlier ENABLE Act, which addressed key provisions related to ABLE accounts.
Currently, over 162,000 ABLE accounts exist, allowing individuals with disabilities to save tax-free without losing access to essential federal benefits. The new legislation aims to provide financial security and flexibility for workers with disabilities, encouraging their employment and savings.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Eric Schmitt Net Worth
Quiver Quantitative estimates that Eric Schmitt is worth $982.7K, as of August 29th, 2025. This is the 330th highest net worth in Congress, per our live estimates.
Schmitt has approximately $622.7K invested in publicly traded assets which Quiver is able to track live.
You can track Eric Schmitt's net worth on Quiver Quantitative's politician page for Schmitt.
Eric Schmitt Bill Proposals
Here are some bills which have recently been proposed by Eric Schmitt:
- S.2278: Graham Hoffman Act
- S.2269: PRICE Act
- S.2206: A bill to amend the Internal Revenue Code of 1986 to increase the limitation on distributions from 529 accounts for qualified higher education expenses.
- S.2067: Rescissions Act of 2025
- S.2002: REMIT Act
- S.1989: Helping Communities with Better Support Act
You can track bills proposed by Eric Schmitt on Quiver Quantitative's politician page for Schmitt.
Eric Schmitt Fundraising
Eric Schmitt recently disclosed $329.3K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 269th most from all Q2 reports we have seen this year. 89.4% came from individual donors.
Schmitt disclosed $238.4K of spending. This was the 217th most from all Q2 reports we have seen from politicians so far this year.
Schmitt disclosed $816.6K of cash on hand at the end of the filing period. This was the 347th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Eric Schmitt's fundraising on Quiver Quantitative.
Rep. Steube introduces the GRACE Act, prohibiting federal education funding for schools denying religious vaccine exemptions.
Quiver AI Summary
U.S. Representative Greg Steube (R-Fla.) has introduced the Guaranteeing Religious Accommodation in Childhood Education (GRACE) Act, which aims to prohibit federal funding for educational institutions that do not grant students religious exemptions from vaccine mandates. Steube emphasized the importance of protecting religious freedom in education, stating, "No student or their family should ever be coerced into sacrificing their faith."
The proposed legislation has garnered support from 14 cosponsors and over fifty organizations, including advocacy groups like Moms for Liberty and Children's Health Defense. The Act's proponents argue it reinforces parental rights and religious freedoms in the context of education.
Steube's announcement includes endorsements from various advocates highlighting the need for protection against states that do not recognize the right to religious exemptions for vaccinations. The full text of the GRACE Act is available for review.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Gregory Steube Net Worth
Quiver Quantitative estimates that Gregory Steube is worth $816.9K, as of August 29th, 2025. This is the 348th highest net worth in Congress, per our live estimates.
Steube has approximately $612.4K invested in publicly traded assets which Quiver is able to track live.
You can track Gregory Steube's net worth on Quiver Quantitative's politician page for Steube.
Gregory Steube Bill Proposals
Here are some bills which have recently been proposed by Gregory Steube:
- H.R.5006: Health Privacy From Global Bureaucrats Act
- H.R.4972: Create Accountable Respectful Environments (CARE) for Children Act
- H.R.4963: Marijuana 1-to-3 Act of 2025
- H.R.4941: Limiting Extremist Travel to the United Nations Act
- H.R.4940: AIRFARE Act
- H.R.4902: Securing Academia from Foreign Entanglements Act
You can track bills proposed by Gregory Steube on Quiver Quantitative's politician page for Steube.
Gregory Steube Fundraising
Gregory Steube recently disclosed $175.4K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 485th most from all Q2 reports we have seen this year. 53.8% came from individual donors.
Steube disclosed $116.6K of spending. This was the 450th most from all Q2 reports we have seen from politicians so far this year.
Steube disclosed $1.7M of cash on hand at the end of the filing period. This was the 178th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Gregory Steube's fundraising on Quiver Quantitative.
U.S. Senators Van Hollen and Alsobrooks announce over $1.2 million in federal funding for Eastern Shore colleges.
Quiver AI Summary
U.S. Senators Chris Van Hollen and Angela Alsobrooks have announced over $1.2 million in federal funding aimed at supporting students at Eastern Shore colleges. The funding, totaling $1,214,311, targets low-income, first-generation students, and those with disabilities, facilitating their educational pursuits.
Senator Van Hollen emphasized, “These federal investments will enable the Eastern Shore’s colleges to provide students with the resources they need to overcome obstacles and succeed,” while Senator Alsobrooks remarked on the importance of education in unlocking opportunities and contributing to the economy.
The funds are allocated from the U.S. Department of Education's TRIO Student Support Services grant program, with Chesapeake College receiving $669,583, and both Wor-Wic Community College and Salisbury University getting $272,364 each.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Chris Van Hollen Bill Proposals
Here are some bills which have recently been proposed by Chris Van Hollen:
- S.2590: Fresh Start Act of 2025
- S.2438: Transformation to Competitive Integrated Employment Act
- S.2369: Francis G. Newlands Memorial Removal Act
- S.2266: Consumer Online Payment Transparency and Integrity Act
- S.2236: YALI Act of 2025
- S.2224: Taiwan International Solidarity Act
You can track bills proposed by Chris Van Hollen on Quiver Quantitative's politician page for Van Hollen.
Chris Van Hollen Fundraising
Chris Van Hollen recently disclosed $244.1K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 355th most from all Q2 reports we have seen this year. 95.7% came from individual donors.
Van Hollen disclosed $111.6K of spending. This was the 464th most from all Q2 reports we have seen from politicians so far this year.
Van Hollen disclosed $2.2M of cash on hand at the end of the filing period. This was the 142nd most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Chris Van Hollen's fundraising on Quiver Quantitative.
Congresswoman Rosa DeLauro comments on the release of New Haven student Esdrás R. from ICE detention.
Quiver AI Summary
Congresswoman Rosa DeLauro (CT-03) expressed relief following the release of Esdrás R., a Wilbur Cross High School student, from ICE detention. DeLauro highlighted community support, stating, "He should have been attending his first week of school, and now he will have the opportunity to come home."
She criticized the Trump Administration's immigration policies, noting that many, like Esdrás, are disproportionately impacted, stating, "I was proud to write a letter in support of Esdrás' release." DeLauro reaffirmed her commitment to supporting due process rights.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Rosa L. DeLauro Net Worth
Quiver Quantitative estimates that Rosa L. DeLauro is worth $3.2M, as of August 29th, 2025. This is the 213th highest net worth in Congress, per our live estimates.
DeLauro has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Rosa L. DeLauro's net worth on Quiver Quantitative's politician page for DeLauro.
Rosa L. DeLauro Bill Proposals
Here are some bills which have recently been proposed by Rosa L. DeLauro:
- H.R.4648: Access to Fertility Treatment and Care Act
- H.R.4647: Captain Paul W. Bud Bucha VA Medical Center Act of 2025
- H.R.4557: BEACON Act
- H.R.4253: Expanding Access to Mental Health Services in Schools Act of 2025
- H.R.3508: End Diaper Need Act of 2025
- H.R.3335: Children Don't Belong on Tobacco Farms Act
You can track bills proposed by Rosa L. DeLauro on Quiver Quantitative's politician page for DeLauro.
Rosa L. DeLauro Fundraising
Rosa L. DeLauro recently disclosed $211.1K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 409th most from all Q2 reports we have seen this year. 59.5% came from individual donors.
DeLauro disclosed $173.8K of spending. This was the 313th most from all Q2 reports we have seen from politicians so far this year.
DeLauro disclosed $172.9K of cash on hand at the end of the filing period. This was the 694th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Rosa L. DeLauro's fundraising on Quiver Quantitative.
Senator Warnock visited Three Bees Pecan Farm to address tariff impacts on Georgia farmers, emphasizing trade and market access.
Quiver AI Summary
U.S. Senator Reverend Raphael Warnock visited Three Bees Pecan Farm in Georgia to discuss the negative impact of ongoing tariff policies on local farmers. Warnock emphasized that such tariffs are detrimental to agricultural operations, complicating their ability to sustain profits and invest in the future. He stated, "These tariffs are not just abstract policies; they’re a tax that affects grocery store prices."
During the tour, Warnock listened to concerns from local producers, including Jeb Barrow Jr., who noted that higher tariffs are reducing exports to China and limiting market opportunities. Warnock has previously worked to lower trade barriers, helping to reduce them with India by 70% in 2022, which is critical for pecan exports, as 28% of U.S. pecans are sold internationally.
The visit aimed to shed light on the agricultural industry's struggle with uncertainty stemming from tariff policies, highlighting Warnock's commitment to addressing the issues faced by Georgia farmers. He aims for bipartisan discussions to foster reasonable trade solutions, emphasizing the importance of supporting American agriculture.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Raphael G. Warnock Net Worth
Quiver Quantitative estimates that Raphael G. Warnock is worth $1.4M, as of August 29th, 2025. This is the 290th highest net worth in Congress, per our live estimates.
Warnock has approximately $34.6K invested in publicly traded assets which Quiver is able to track live.
You can track Raphael G. Warnock's net worth on Quiver Quantitative's politician page for Warnock.
Raphael G. Warnock Bill Proposals
Here are some bills which have recently been proposed by Raphael G. Warnock:
- S.2628: Catastrophic Specialty Hospital Act of 2025
- S.2454: Fair Debt Collection Practices for Servicemembers Act
- S.2322: Appraisal Modernization Act
- S.2131: Dads Matter Act of 2025
- S.2050: ASSIST Act
- S.1939: BARK Act of 2025
You can track bills proposed by Raphael G. Warnock on Quiver Quantitative's politician page for Warnock.
Raphael G. Warnock Fundraising
Raphael G. Warnock recently disclosed $238.9K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 364th most from all Q2 reports we have seen this year. 97.9% came from individual donors.
Warnock disclosed $540.4K of spending. This was the 78th most from all Q2 reports we have seen from politicians so far this year.
Warnock disclosed $4.2M of cash on hand at the end of the filing period. This was the 55th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Raphael G. Warnock's fundraising on Quiver Quantitative.
Congressman Joaquin Castro criticizes Governor Abbott for signing a controversial Texas congressional map, alleging voter suppression.
Quiver AI Summary
U.S. Congressman Joaquin Castro criticized Texas Governor Greg Abbott for signing a new redistricting map into law, calling it illegal and a form of voter suppression that disproportionately affects Latino and Black communities. Castro stated, "This isn’t democracy at work" and expressed his intention to fight the ruling in court to protect voting rights.
He accused Republican lawmakers of manipulating the system to maintain power, emphasizing that the consequences of this gerrymandering would negatively impact all Texans. Castro affirmed his commitment to defending democratic processes in Texas and across the nation.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Joaquin Castro Bill Proposals
Here are some bills which have recently been proposed by Joaquin Castro:
- H.R.4490: PARTNER Act
- H.R.4489: Sunshine on Solar Lending Act
- H.R.4319: Strengthening Science Through Diplomacy Act of 2025
- H.R.4318: Head Start for Our Future Act
- H.R.3865: PARTNER with ASEAN Act of 2025
- H.R.3678: Strengthening US-Caribbean Partnership Act
You can track bills proposed by Joaquin Castro on Quiver Quantitative's politician page for Castro.
Joaquin Castro Fundraising
Joaquin Castro recently disclosed $104.7K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 606th most from all Q2 reports we have seen this year. 77.6% came from individual donors.
Castro disclosed $83.5K of spending. This was the 563rd most from all Q2 reports we have seen from politicians so far this year.
Castro disclosed $168.0K of cash on hand at the end of the filing period. This was the 700th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Joaquin Castro's fundraising on Quiver Quantitative.
Senator Jacky Rosen introduces the HOME Act to combat corporate price gouging in Nevada's housing market.
Quiver AI Summary
U.S. Senator Jacky Rosen (D-NV) has introduced the Housing Oversight and Mitigating Exploitation (HOME) Act, aimed at reducing housing costs for Nevada families. The bill is designed to combat price gouging by corporate investors who purchase large quantities of homes, driving up prices in the housing market.
Senator Rosen stated, “Hardworking Nevada families are being squeezed by rising costs... I’m introducing this bill to crack down on corporate price gouging in the housing market and lower costs for Nevadans.” The legislation also seeks to support local families in achieving homeownership.
The bill has garnered media attention, highlighting concerns from Nevadans about the impact of corporate buying on housing affordability. Rosen emphasized the importance of ensuring every family can access affordable housing and strengthen Nevada communities.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Jacky Rosen Net Worth
Quiver Quantitative estimates that Jacky Rosen is worth $16.7M, as of August 29th, 2025. This is the 77th highest net worth in Congress, per our live estimates.
Rosen has approximately $4.8M invested in publicly traded assets which Quiver is able to track live.
You can track Jacky Rosen's net worth on Quiver Quantitative's politician page for Rosen.
Jacky Rosen Bill Proposals
Here are some bills which have recently been proposed by Jacky Rosen:
- S.2617: Reducing Drug Prices for Seniors Act.
- S.2521: Provider Training in Palliative Care Act
- S.2494: Hire Student Veterans Act
- S.2443: Veterans Jobs Opportunity Act
- S.2331: Extreme Heat Emergency Act of 2025
- S.2306: STEM RESTART Act
You can track bills proposed by Jacky Rosen on Quiver Quantitative's politician page for Rosen.
Jacky Rosen Fundraising
Jacky Rosen recently disclosed $198.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 437th most from all Q2 reports we have seen this year. 87.4% came from individual donors.
Rosen disclosed $290.2K of spending. This was the 169th most from all Q2 reports we have seen from politicians so far this year.
Rosen disclosed $923.4K of cash on hand at the end of the filing period. This was the 318th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Jacky Rosen's fundraising on Quiver Quantitative.
Congresswomen Bynum and Salinas convened a roundtable in Silverton discussing rural economic development with local leaders and organizations.
Quiver AI Summary
On August 28, 2025, Congresswomen Janelle Bynum (OR-05) and Andrea Salinas (OR-06) hosted a roundtable discussion in Silverton focused on rural economic development. The event included local government officials, nonprofit leaders, and business representatives, emphasizing challenges and opportunities within Oregon's rural areas.
Rep. Bynum highlighted the importance of rural small businesses in fostering community resilience, while Rep. Salinas pointed out the need for investments in infrastructure and accessibility to federal programs. Both representatives expressed their commitment to advocating for rural communities in Congress.
The meeting was part of the New Democrat Coalition's "New Dems on the Road Tour," aimed at engaging with local leaders to address economic growth and job creation in rural regions.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Janelle Bynum Net Worth
Quiver Quantitative estimates that Janelle Bynum is worth $16.1M, as of August 29th, 2025. This is the 81st highest net worth in Congress, per our live estimates.
Bynum has approximately $427.6K invested in publicly traded assets which Quiver is able to track live.
You can track Janelle Bynum's net worth on Quiver Quantitative's politician page for Bynum.
Janelle Bynum Bill Proposals
Here are some bills which have recently been proposed by Janelle Bynum:
- H.R.4486: Microplastics Safety Act
- H.R.2537: Deschutes River Conservancy Reauthorization Act of 2025
- H.R.2287: Protecting Families from Inflation Act
You can track bills proposed by Janelle Bynum on Quiver Quantitative's politician page for Bynum.
Janelle Bynum Fundraising
Janelle Bynum recently disclosed $660.1K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 98th most from all Q2 reports we have seen this year. 70.0% came from individual donors.
Bynum disclosed $179.0K of spending. This was the 302nd most from all Q2 reports we have seen from politicians so far this year.
Bynum disclosed $857.4K of cash on hand at the end of the filing period. This was the 334th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Janelle Bynum's fundraising on Quiver Quantitative.
Hakeem Jeffries criticizes Trump's actions as unconstitutional, asserting Congress's exclusive power over budget matters.
Quiver AI Summary
House Democratic Leader Hakeem Jeffries issued a statement criticizing former President Donald Trump, claiming he has presented "a brazenly unlawful scam to Congress" to divert taxpayer funds ahead of an upcoming government funding deadline. Jeffries emphasized that the Constitution grants Congress control over fiscal matters and condemned Republicans for abandoning bipartisan efforts.
Jeffries further stated, "If there is a government shutdown, it will directly result from an out-of-control administration and compliant House Republicans," accusing them of pursuing an extreme agenda that jeopardizes national security and neglects the needs of Americans.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Hakeem S. Jeffries Net Worth
Quiver Quantitative estimates that Hakeem S. Jeffries is worth $586.5K, as of August 29th, 2025. This is the 384th highest net worth in Congress, per our live estimates.
Jeffries has approximately $160.0K invested in publicly traded assets which Quiver is able to track live.
You can track Hakeem S. Jeffries's net worth on Quiver Quantitative's politician page for Jeffries.
Hakeem S. Jeffries Bill Proposals
Here are some bills which have recently been proposed by Hakeem S. Jeffries:
- H.R.19: Reserved for the Minority Leader.
- H.R.18: Reserved for the Minority Leader.
- H.R.13: Reserved for the Minority Leader.
You can track bills proposed by Hakeem S. Jeffries on Quiver Quantitative's politician page for Jeffries.
Hakeem S. Jeffries Fundraising
Hakeem S. Jeffries recently disclosed $2.1M of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 14th most from all Q2 reports we have seen this year. 81.6% came from individual donors.
Jeffries disclosed $2.2M of spending. This was the 9th most from all Q2 reports we have seen from politicians so far this year.
Jeffries disclosed $6.3M of cash on hand at the end of the filing period. This was the 34th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Hakeem S. Jeffries's fundraising on Quiver Quantitative.
Senator Reed criticizes Trump for attempts to bypass Congress, warning of a potential government shutdown due to funding disputes.
Quiver AI Summary
Senator Jack Reed has criticized President Donald Trump's attempts to override bipartisan spending laws, claiming it may lead to a federal government shutdown. Reed argues that by using a "pocket recission" to cancel nearly $5 billion in approved funding, Trump is acting unlawfully and jeopardizing essential programs, including education and public health.
Reed stated, "If President Trump insists on grinding the federal government to a halt, it would take a two-thirds vote in Congress to stop him." He urged Congressional Republicans to resist Trump's actions, emphasizing the need for adherence to the Constitution and support for crucial federal programs.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Jack Reed Net Worth
Quiver Quantitative estimates that Jack Reed is worth $308.0K, as of August 29th, 2025. This is the 428th highest net worth in Congress, per our live estimates.
Reed has approximately $251.5K invested in publicly traded assets which Quiver is able to track live.
You can track Jack Reed's net worth on Quiver Quantitative's politician page for Reed.
Jack Reed Bill Proposals
Here are some bills which have recently been proposed by Jack Reed:
- S.2338: Strengthening Local Food Security Act of 2025
- S.1904: Ending Taxpayer Support for Big Egg Producers Act
- S.1903: A bill to prohibit changes to Medicare and Medicaid in reconciliation.
- S.1576: Stop Subsidizing Multimillion Dollar Corporate Bonuses Act
- S.1467: Homebuyers Privacy Protection Act
- S.1342: Weatherization Assistance Program Improvements Act of 2025
You can track bills proposed by Jack Reed on Quiver Quantitative's politician page for Reed.
Jack Reed Fundraising
Jack Reed recently disclosed $652.6K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 105th most from all Q2 reports we have seen this year. 59.9% came from individual donors.
Reed disclosed $206.1K of spending. This was the 258th most from all Q2 reports we have seen from politicians so far this year.
Reed disclosed $2.5M of cash on hand at the end of the filing period. This was the 114th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Jack Reed's fundraising on Quiver Quantitative.
Gwen Moore and Wisconsin lawmakers urge Trump to approve FEMA disaster assistance for flooding recovery efforts.
Quiver AI Summary
Congresswoman Gwen Moore, along with Wisconsin's congressional delegation, is urging President Trump to approve Governor Evers' request for federal assistance following severe flooding in Milwaukee. The request aims to secure a major disaster declaration, which would activate FEMA's Individual Assistance and Public Assistance programs.
In a joint letter, they noted the flooding caused "tens of millions in damage" and emphasized the need for federal support to assist families and local governments in recovery. Moore highlighted the importance of a swift response from the President and expressed pride in the bipartisan effort for aid.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Gwen Moore Bill Proposals
Here are some bills which have recently been proposed by Gwen Moore:
- H.R.3820: To name the Department of Veterans Affairs women's health clinic in Milwaukee, Wisconsin, as the Anna Mae Robertson VA Well Woman Clinic.
- H.R.3517: Social Security Enhancement and Protection Act of 2025
- H.R.3249: Mom and Pop Tax Relief Act
- H.R.2567: To amend the Internal Revenue Code of 1986 to provide special rules for purposes of determining if financial guaranty insurance companies are qualifying insurance corporations under the passive foreign investment company rules.
- H.R.2338: WRCR Act of 2025
- H.R.2146: To amend the Internal Revenue Code of 1986 to provide refunds with respect to certain dyed fuels that are exempt from tax and with respect to which tax was previously paid.
You can track bills proposed by Gwen Moore on Quiver Quantitative's politician page for Moore.
Gwen Moore Fundraising
Gwen Moore recently disclosed $182.5K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 471st most from all Q2 reports we have seen this year. 40.5% came from individual donors.
Moore disclosed $180.8K of spending. This was the 298th most from all Q2 reports we have seen from politicians so far this year.
Moore disclosed $49.8K of cash on hand at the end of the filing period. This was the 889th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Gwen Moore's fundraising on Quiver Quantitative.
Congressman Eric Burlison introduces the UAP Disclosure Act of 2025 to enhance transparency on government UAP records.
Quiver AI Summary
Congressman Eric Burlison (MO-07) has introduced the Unidentified Anomalous Phenomena (UAP) Disclosure Act of 2025 as an amendment to the FY 2026 National Defense Authorization Act. The initiative aims to enhance transparency regarding government records on UAPs.
Rep. Burlison stated, "For too long, Americans have been left in the dark about UAP," emphasizing the need for public access to these records. The amendment seeks to prevent the destruction of UAP records, establish a collection at the National Archives, and mandate transparency.
If adopted, the amendment would allow for public disclosure of UAP records within 25 years unless there are national security concerns. "This effort is about transparency and trust," Burlison concluded.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Eric Burlison Net Worth
Quiver Quantitative estimates that Eric Burlison is worth $1.0M, as of August 29th, 2025. This is the 328th highest net worth in Congress, per our live estimates.
Burlison has approximately $460.8K invested in publicly traded assets which Quiver is able to track live.
You can track Eric Burlison's net worth on Quiver Quantitative's politician page for Burlison.
Eric Burlison Bill Proposals
Here are some bills which have recently been proposed by Eric Burlison:
- H.R.4756: Freights First Act
- H.R.4123: FIT Procurement Act
- H.R.3949: Propane Accessibility and Regulatory Relief Act
- H.R.3905: Judicial Review Timeline Clarity Act
- H.R.3751: Reliable Grid Act
- H.R.2409: Guidance Clarity Act
You can track bills proposed by Eric Burlison on Quiver Quantitative's politician page for Burlison.
Eric Burlison Fundraising
Eric Burlison recently disclosed $279.9K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 309th most from all Q2 reports we have seen this year. 82.0% came from individual donors.
Burlison disclosed $154.9K of spending. This was the 359th most from all Q2 reports we have seen from politicians so far this year.
Burlison disclosed $752.8K of cash on hand at the end of the filing period. This was the 362nd most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Eric Burlison's fundraising on Quiver Quantitative.
We just received data on a new analyst forecast for $PRVA. David M. Scharf from JMP Securities set a price target of 30.0 for PRVA.
To track analyst ratings and price targets for $PRVA, check out Quiver Quantitative's $PRVA forecast page.
$PRVA Price Targets
Multiple analysts have issued price targets for $PRVA recently. We have seen 10 analysts offer price targets for $PRVA in the last 6 months, with a median target of $29.5.
Here are some recent targets:
- David M. Scharf from JMP Securities set a target price of $30.0 on 08/29/2025
- Sean Wieland from Piper Sandler set a target price of $36.0 on 08/11/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 07/09/2025
- Lisa Gill from JP Morgan set a target price of $32.0 on 05/28/2025
- Andrew Mok from Barclays set a target price of $24.0 on 05/27/2025
- Michael Ha from Baird set a target price of $26.0 on 04/15/2025
- Jailendra Singh from Truist Securities set a target price of $28.0 on 04/10/2025
$PRVA Insider Trading Activity
$PRVA insiders have traded $PRVA stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $PRVA stock by insiders over the last 6 months:
- PARTH MEHROTRA (Chief Executive Officer) has made 0 purchases and 7 sales selling 91,595 shares for an estimated $2,198,404.
- DAVID MOUNTCASTLE (EVP & Chief Financial Officer) has made 0 purchases and 5 sales selling 18,248 shares for an estimated $431,046.
- MATTHEW SHAWN MORRIS sold 10,309 shares for an estimated $240,508
- EDWARD C FARGIS (EVP & General Counsel) has made 0 purchases and 2 sales selling 4,967 shares for an estimated $120,255.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PRVA Hedge Fund Activity
We have seen 152 institutional investors add shares of $PRVA stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 3,981,833 shares (-22.2%) from their portfolio in Q2 2025, for an estimated $91,582,159
- WELLINGTON MANAGEMENT GROUP LLP removed 1,650,288 shares (-88.4%) from their portfolio in Q2 2025, for an estimated $37,956,624
- BANK OF AMERICA CORP /DE/ removed 1,353,571 shares (-52.8%) from their portfolio in Q2 2025, for an estimated $31,132,133
- VAN BERKOM & ASSOCIATES INC. added 887,549 shares (+44.1%) to their portfolio in Q2 2025, for an estimated $20,413,627
- SOROS FUND MANAGEMENT LLC removed 700,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $15,715,000
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 674,411 shares (+117.8%) to their portfolio in Q2 2025, for an estimated $15,511,453
- RIVERBRIDGE PARTNERS LLC removed 569,799 shares (-10.3%) from their portfolio in Q2 2025, for an estimated $13,105,377
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
We just received data on a new analyst forecast for $MOV. Hamed Khorsand from BWS Financial set a price target of 31.5 for MOV.
To track analyst ratings and price targets for $MOV, check out Quiver Quantitative's $MOV forecast page.
$MOV Hedge Fund Activity
We have seen 75 institutional investors add shares of $MOV stock to their portfolio, and 89 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BRANDES INVESTMENT PARTNERS, LP added 363,296 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,540,264
- MILLENNIUM MANAGEMENT LLC removed 256,826 shares (-67.8%) from their portfolio in Q2 2025, for an estimated $3,916,596
- DEPRINCE RACE & ZOLLO INC added 179,959 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,744,374
- CITADEL ADVISORS LLC removed 147,215 shares (-88.6%) from their portfolio in Q2 2025, for an estimated $2,245,028
- RUSSELL INVESTMENTS GROUP, LTD. added 142,601 shares (+426.8%) to their portfolio in Q2 2025, for an estimated $2,174,665
- ROYCE & ASSOCIATES LP added 137,714 shares (+8.5%) to their portfolio in Q2 2025, for an estimated $2,100,138
- TREXQUANT INVESTMENT LP added 112,524 shares (+124.3%) to their portfolio in Q2 2025, for an estimated $1,715,991
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
We just received data on a new analyst forecast for $BRZE. Matthew Vanvliet from Cantor Fitzgerald set a price target of 35.0 for BRZE.
To track analyst ratings and price targets for $BRZE, check out Quiver Quantitative's $BRZE forecast page.
$BRZE Price Targets
Multiple analysts have issued price targets for $BRZE recently. We have seen 19 analysts offer price targets for $BRZE in the last 6 months, with a median target of $43.0.
Here are some recent targets:
- Matthew Vanvliet from Cantor Fitzgerald set a target price of $35.0 on 08/29/2025
- Ryan Macwilliams from Barclays set a target price of $35.0 on 08/18/2025
- Siti Panigrahi from Mizuho set a target price of $40.0 on 07/24/2025
- Brian Schwartz from Oppenheimer set a target price of $38.0 on 06/24/2025
- Yun Kim from Loop Capital set a target price of $45.0 on 06/06/2025
- Ross Compton from Macquarie set a target price of $35.0 on 06/06/2025
- Taylor McGinnis from UBS set a target price of $48.0 on 06/06/2025
$BRZE Insider Trading Activity
$BRZE insiders have traded $BRZE stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $BRZE stock by insiders over the last 6 months:
- WILLIAM MAGNUSON (Chief Executive Officer) has made 0 purchases and 2 sales selling 49,414 shares for an estimated $1,531,183.
- ASTHA MALIK (Chief Business Officer) has made 0 purchases and 3 sales selling 35,510 shares for an estimated $1,091,555.
- ISABELLE WINKLES (Chief Financial Officer) has made 0 purchases and 2 sales selling 22,988 shares for an estimated $712,328.
- SUSAN WISEMAN (General Counsel) has made 0 purchases and 5 sales selling 24,027 shares for an estimated $696,885.
- JONATHAN HYMAN (Chief Technology Officer) has made 0 purchases and 2 sales selling 18,115 shares for an estimated $561,321.
- INC. BRAZE, (Chief Business Officer) sold 13,460 shares for an estimated $482,944
- MYLES KLEEGER (Pres & CCO) sold 9,189 shares for an estimated $329,701
- PANKAJ MALIK (Chief Accounting Officer) has made 0 purchases and 2 sales selling 5,749 shares for an estimated $182,974.
- PHILLIP M FERNANDEZ sold 1,500 shares for an estimated $62,190
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BRZE Hedge Fund Activity
We have seen 135 institutional investors add shares of $BRZE stock to their portfolio, and 157 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CADIAN CAPITAL MANAGEMENT, LP removed 1,905,128 shares (-41.8%) from their portfolio in Q2 2025, for an estimated $53,534,096
- CITADEL ADVISORS LLC added 1,767,270 shares (+382.2%) to their portfolio in Q2 2025, for an estimated $49,660,287
- INVESCO LTD. removed 1,686,963 shares (-94.7%) from their portfolio in Q2 2025, for an estimated $47,403,660
- MILLENNIUM MANAGEMENT LLC added 1,611,660 shares (+155.8%) to their portfolio in Q2 2025, for an estimated $45,287,646
- FULLER & THALER ASSET MANAGEMENT, INC. removed 1,413,061 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $39,707,014
- FIERA CAPITAL CORP removed 908,045 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $25,516,064
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND removed 732,800 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $20,591,680
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
We just received data on a new analyst forecast for $NTAP. Jim Kelleher from Argus Research set a price target of 130.0 for NTAP.
To track analyst ratings and price targets for $NTAP, check out Quiver Quantitative's $NTAP forecast page.
$NTAP Price Targets
Multiple analysts have issued price targets for $NTAP recently. We have seen 12 analysts offer price targets for $NTAP in the last 6 months, with a median target of $117.5.
Here are some recent targets:
- Jim Kelleher from Argus Research set a target price of $130.0 on 08/29/2025
- Nehal Chokshi from Northland Capital Markets set a target price of $120.0 on 08/28/2025
- Tim Long from Barclays set a target price of $125.0 on 08/28/2025
- David Vogt from UBS set a target price of $114.0 on 08/28/2025
- Wamsi Mohan from B of A Securities set a target price of $125.0 on 08/25/2025
- Erik Woodring from Morgan Stanley set a target price of $115.0 on 08/21/2025
- Asiya Merchant from Citigroup set a target price of $115.0 on 08/11/2025
$NTAP Insider Trading Activity
$NTAP insiders have traded $NTAP stock on the open market 19 times in the past 6 months. Of those trades, 3 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $NTAP stock by insiders over the last 6 months:
- GEORGE KURIAN (CEO) has made 0 purchases and 8 sales selling 51,000 shares for an estimated $5,042,012.
- CESAR CERNUDA (President) has made 0 purchases and 2 sales selling 19,696 shares for an estimated $1,775,523.
- ANDERS GUSTAFSSON has made 3 purchases buying 5,524 shares for an estimated $499,597 and 0 sales.
- ELIZABETH M O'CALLAHAN (EVP, Chief Admin. Officer) has made 0 purchases and 4 sales selling 2,980 shares for an estimated $305,692.
- LORENZO DANIEL DE (VP, Controller & CAO) has made 0 purchases and 2 sales selling 628 shares for an estimated $62,422.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTAP Hedge Fund Activity
We have seen 454 institutional investors add shares of $NTAP stock to their portfolio, and 482 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 4,175,260 shares (+19079.1%) to their portfolio in Q2 2025, for an estimated $444,873,953
- BOSTON PARTNERS added 1,536,339 shares (+108.9%) to their portfolio in Q2 2025, for an estimated $163,696,920
- GEODE CAPITAL MANAGEMENT, LLC added 1,024,626 shares (+16.8%) to their portfolio in Q2 2025, for an estimated $109,173,900
- LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT added 931,850 shares (+1230.3%) to their portfolio in Q2 2025, for an estimated $99,288,617
- ACADIAN ASSET MANAGEMENT LLC removed 776,808 shares (-63.8%) from their portfolio in Q2 2025, for an estimated $82,768,892
- JPMORGAN CHASE & CO added 768,914 shares (+51.7%) to their portfolio in Q2 2025, for an estimated $81,927,786
- ALLIANZ ASSET MANAGEMENT GMBH removed 733,810 shares (-36.4%) from their portfolio in Q2 2025, for an estimated $78,187,455
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Senator Steve Daines has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $5,000,000 in Ag Land Belgrade
- Up to $5,000,000 in Gen 3
- Up to $5,000,000 in Vanguard Federal Money Market Fund (Settlement fund)
- Up to $5,000,000 in Gen 7
- Up to $5,000,000 in Residential/Agricultural Property
You can see all their disclosed assets on the Quiver Quantitative politician page for Daines.
You can track politicians' wealth on our live net worth tracker.
Senator Steve Daines Net Worth
Quiver Quantitative estimates that Senator Steve Daines is worth $21.4M, as of August 29th, 2025. This is the 59th highest net worth in Congress, per our live estimates.
Daines has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Senator Steve Daines's net worth on Quiver Quantitative's politician page for Daines.
Senator Steve Daines Stock Trading
We have data on up to $100.0K of trades from Senator Steve Daines, which we parsed from STOCK Act filings.
You can track Senator Steve Daines's stock trading on Quiver Quantitative's politician page for Daines.
Senator Steve Daines Bill Proposals
Here are some bills which have recently been proposed by Senator Steve Daines:
- S.2577: McCarran-Walter Technical Corrections Act
- S.2461: Promotion and Expansion of Private Employee Ownership Act of 2025
- S.1967: PROTECT Act of 2025
- S.1912: Protecting Veteran Community Care Act
- S.1858: A bill to require that national cemeteries be open to visitors on legal public holidays.
- S.1696: DRIVE Act
You can track bills proposed by Senator Steve Daines on Quiver Quantitative's politician page for Daines.
Senator Steve Daines Fundraising
Senator Steve Daines recently disclosed $678.9K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 92nd most from all Q2 reports we have seen this year. 55.4% came from individual donors.
Daines disclosed $280.5K of spending. This was the 178th most from all Q2 reports we have seen from politicians so far this year.
Daines disclosed $3.3M of cash on hand at the end of the filing period. This was the 81st most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Senator Steve Daines's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Senator Tammy Duckworth has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $250,000 in USAA
- Up to $100,000 in Lincoln Shareholdrs Adv Old Contract #953048073
- Up to $50,000 in AIVSX - American Funds Investment CO of America A
- Up to $50,000 in Bright Directions 529 Mod Age Bsd 09-10 C
- Up to $50,000 in VEU - Vanguard FTSE All World Ex US ETF
You can see all their disclosed assets on the Quiver Quantitative politician page for Duckworth.
You can track politicians' wealth on our live net worth tracker.
Senator Tammy Duckworth Net Worth
Quiver Quantitative estimates that Senator Tammy Duckworth is worth $1.3M, as of August 29th, 2025. This is the 299th highest net worth in Congress, per our live estimates.
Duckworth has approximately $790.1K invested in publicly traded assets which Quiver is able to track live.
You can track Senator Tammy Duckworth's net worth on Quiver Quantitative's politician page for Duckworth.
Senator Tammy Duckworth Stock Trading
We have data on up to $1.0M of trades from Senator Tammy Duckworth, which we parsed from STOCK Act filings. Some of the largest trades include:
- A June 16th, 2017 sale of up to $50K of $NEE. The stock has risen 101.9% since then.
- A April 11th, 2023 sale of up to $50K of $ITW. The stock has risen 14.84% since then.
- A April 5th, 2021 sale of up to $50K of $VZ. The stock has fallen 24.91% since then.
- A June 5th, 2017 sale of up to $15K of $CAT. The stock has risen 296.02% since then.
- A August 7th, 2018 sale of up to $15K of $MDLZ. The stock has risen 42.93% since then.
You can track Senator Tammy Duckworth's stock trading on Quiver Quantitative's politician page for Duckworth.
Senator Tammy Duckworth Bill Proposals
Here are some bills which have recently been proposed by Senator Tammy Duckworth:
- S.2377: EACH Act of 2025
- S.2239: Improving Access to Prenatal Care for Military Families Act
- S.2199: A bill to require the Secretary of Defense to issue regulations requiring that optional combat boots worn by members of the Armed Forces wear be made in the United States, and for other purposes.
- S.2198: Military in Law Enforcement Accountability Act
- S.2162: Kangaroo Protection Act of 2025
- S.2035: Protect IVF Act
You can track bills proposed by Senator Tammy Duckworth on Quiver Quantitative's politician page for Duckworth.
Senator Tammy Duckworth Fundraising
Senator Tammy Duckworth recently disclosed $961.0K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 42nd most from all Q2 reports we have seen this year. 98.2% came from individual donors.
Duckworth disclosed $711.5K of spending. This was the 52nd most from all Q2 reports we have seen from politicians so far this year.
Duckworth disclosed $3.4M of cash on hand at the end of the filing period. This was the 78th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Senator Tammy Duckworth's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Jennifer Kiggans has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $5,000,000 in CHARLES SCHWAB 401K ⇒ SPOUSE 401K
- Up to $1,000,000 in SANDBRIDGE CONDO
- Up to $250,000 in RAYMOND JAMES ROTH IRA ⇒ ALLSPRING SPECIAL MID CAP VALUE FUND INSTI CLASS (WFMIX)
- Up to $100,000 in USAA SAVINGS ACCOUNT
- Up to $100,000 in RAYMOND JAMES ROTH IRA ⇒ ALLSPRING SPECIAL MID CAP VALUE FUND INSTI CLASS (WFMIX)
You can see all their disclosed assets on the Quiver Quantitative politician page for Kiggans.
You can track politicians' wealth on our live net worth tracker.
Representative Jennifer Kiggans Net Worth
Quiver Quantitative estimates that Representative Jennifer Kiggans is worth $4.2M, as of August 29th, 2025. This is the 183rd highest net worth in Congress, per our live estimates.
Kiggans has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Representative Jennifer Kiggans's net worth on Quiver Quantitative's politician page for Kiggans.
Representative Jennifer Kiggans Bill Proposals
Here are some bills which have recently been proposed by Representative Jennifer Kiggans:
- H.R.4996: FORWARD Act
- H.R.4805: To direct the Secretary of Veterans Affairs to conduct a study on the long-term physiological and psychological effects of military aviation veterans who served as aviators in the Armed Forces, and for other purposes.
- H.R.4686: LIFT Act of 2025
- H.R.4507: TUTOR Act
- H.R.4333: Qualified to Serve Act
- H.R.4185: Integrating Social Workers Across Health Care Settings Act
You can track bills proposed by Representative Jennifer Kiggans on Quiver Quantitative's politician page for Kiggans.
Representative Jennifer Kiggans Fundraising
Representative Jennifer Kiggans recently disclosed $584.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 121st most from all Q2 reports we have seen this year. 70.0% came from individual donors.
Kiggans disclosed $506.2K of spending. This was the 84th most from all Q2 reports we have seen from politicians so far this year.
Kiggans disclosed $1.4M of cash on hand at the end of the filing period. This was the 212th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Jennifer Kiggans's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Kevin Kiley has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $50,000 in GOLDEN ONE CREDIT UNION
- Up to $15,000 in BANK OF AMERICA ACCOUNT
- Up to $15,000 in AG FINANCIAL ⇒ STEWARD AGGR GROWTH STRATEGY
- Up to $15,000 in AG FINANCIAL ⇒ STEWARD BALANCED STRATEGY
You can see all their disclosed assets on the Quiver Quantitative politician page for Kiley.
You can track politicians' wealth on our live net worth tracker.
Representative Kevin Kiley Net Worth
Quiver Quantitative estimates that Representative Kevin Kiley is worth $56.5K, as of August 29th, 2025. This is the 472nd highest net worth in Congress, per our live estimates.
Kiley has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Representative Kevin Kiley's net worth on Quiver Quantitative's politician page for Kiley.
Representative Kevin Kiley Bill Proposals
Here are some bills which have recently been proposed by Representative Kevin Kiley:
- H.R.4889: To prohibit States from carrying out more than one Congressional redistricting after a decennial census and apportionment.
- H.R.4232: No Tax Dollars for Riots
- H.R.3495: Direct Seller and Real Estate Agent Harmonization Act
- H.R.3152: Patent Eligibility Restoration Act of 2025
- H.R.3007: Medicare Protection Act of 2025
- H.R.2634: Free Speech On Campus Act
You can track bills proposed by Representative Kevin Kiley on Quiver Quantitative's politician page for Kiley.
Representative Kevin Kiley Fundraising
Representative Kevin Kiley recently disclosed $394.6K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 221st most from all Q2 reports we have seen this year. 79.0% came from individual donors.
Kiley disclosed $152.1K of spending. This was the 365th most from all Q2 reports we have seen from politicians so far this year.
Kiley disclosed $1.4M of cash on hand at the end of the filing period. This was the 217th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Kevin Kiley's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Monica De La Cruz has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $500,000 in JSM DE LA CRUZ HOLDINGS, LLC ⇒ RESIDENTIAL RENTAL PROPERTY 2
- Up to $250,000 in JSM DE LA CRUZ HOLDINGS, LLC ⇒ RESIDENTIAL RENTAL PROPERTY 3
- Up to $250,000 in JSM DE LA CRUZ HOLDINGS, LLC ⇒ FREEDOM BANK ACCOUNTS
- Up to $50,000 in CASH VALUE LIFE INSURANCE ⇒ STATE FARM LIFE INSURANCE ⇒ DC3 WHOLE LIFE INSURANCE POLICY
- Up to $50,000 in STATE FARM 529 SAVINGS PLAN ⇒ DC1 AGE BASED 15-16 PORTFOLIO
You can see all their disclosed assets on the Quiver Quantitative politician page for De La Cruz.
You can track politicians' wealth on our live net worth tracker.
Representative Monica De La Cruz Net Worth
Quiver Quantitative estimates that Representative Monica De La Cruz is worth $1.1M, as of August 29th, 2025. This is the 319th highest net worth in Congress, per our live estimates.
De La Cruz has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Representative Monica De La Cruz's net worth on Quiver Quantitative's politician page for De La Cruz.
Representative Monica De La Cruz Bill Proposals
Here are some bills which have recently been proposed by Representative Monica De La Cruz:
- H.R.4646: Whistleblower Protection Act of 2025
- H.R.4367: To reform the H-2A worker program, and for other purposes.
- H.R.3806: To direct the Secretary of Agriculture to study and report on strategies to combat the New World screwworm and enhance the United States' preparedness and response capabilities against potential outbreaks.
- H.R.3531: Sergeant Alfredo ‘Freddy’ Gonzalez Congressional Gold Medal Act
- H.R.3390: Bringing the Discount Window into the 21st Century Act
- H.R.3233: Healthy Babies Act of 2025
You can track bills proposed by Representative Monica De La Cruz on Quiver Quantitative's politician page for De La Cruz.
Representative Monica De La Cruz Fundraising
Representative Monica De La Cruz recently disclosed $677.9K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 93rd most from all Q2 reports we have seen this year. 75.9% came from individual donors.
De La Cruz disclosed $417.8K of spending. This was the 109th most from all Q2 reports we have seen from politicians so far this year.
De La Cruz disclosed $1.3M of cash on hand at the end of the filing period. This was the 226th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Monica De La Cruz's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Brad Knott has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $5,000,000 in CHARLES SCHWAB BROKERAGE ACCOUNT 1 ⇒ BAYTEX ENERGY CORP COMMON SHARES
- Up to $500,000 in PERSONAL ROTH IRA ⇒ COMPOSECURE, INC. - CLASS A COMMON STOCK
- Up to $250,000 in REAL ESTATE INVESTMENT 1 ⇒ REAL ESTATE INVESTMENT
- Up to $250,000 in REAL ESTATE INVESTMENT 2 ⇒ INLAND STUDENT HOUSING OPPORTUNITY FUND
- Up to $250,000 in CHILD'S 529 PLAN ⇒ AMERICAN FUNDS COLLEGE 2039 FUND CLASS 529-A
You can see all their disclosed assets on the Quiver Quantitative politician page for Knott.
You can track politicians' wealth on our live net worth tracker.
Representative Brad Knott Net Worth
Quiver Quantitative estimates that Representative Brad Knott is worth $4.3M, as of August 29th, 2025. This is the 182nd highest net worth in Congress, per our live estimates.
Knott has approximately $3.6M invested in publicly traded assets which Quiver is able to track live.
You can track Representative Brad Knott's net worth on Quiver Quantitative's politician page for Knott.
Representative Brad Knott Stock Trading
We have data on up to $80.0K of trades from Representative Brad Knott, which we parsed from STOCK Act filings. Some of the largest trades include:
- A January 10th, 2025 sale of up to $50K of $ORMP. The stock has fallen 8.16% since then.
- A January 14th, 2025 purchase of up to $15K of $CMPO. The stock has risen 36.0% since then.
You can track Representative Brad Knott's stock trading on Quiver Quantitative's politician page for Knott.
Representative Brad Knott Bill Proposals
Here are some bills which have recently been proposed by Representative Brad Knott:
- H.R.4070: Tren de Aragua Border Security Threat Assessment Act
- H.R.3242: Punishing Illegal Immigrant Felons Act of 2025
You can track bills proposed by Representative Brad Knott on Quiver Quantitative's politician page for Knott.
Representative Brad Knott Fundraising
Representative Brad Knott recently disclosed $228.0K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 379th most from all Q2 reports we have seen this year. 40.1% came from individual donors.
Knott disclosed $113.6K of spending. This was the 459th most from all Q2 reports we have seen from politicians so far this year.
Knott disclosed $253.5K of cash on hand at the end of the filing period. This was the 607th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Brad Knott's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Teresa Leger Fernandez has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $500,000 in CHARLES SCHWABB IRA ⇒ BAIRD AGGREGATE BOND FUND INSTITUTIONAL CLASS
- Up to $250,000 in CHARLES SCHWABB IRA ⇒ LOOMIS SAYLES CORE PLUS BOND FD CL Y
- Up to $250,000 in CHARLES SCHWABB IRA ⇒ WCM FOCUSED INTERNATIONAL GROWTH FUND INSTI CL (WCMIX)
- Up to $250,000 in CHARLES SCHWABB IRA ⇒ VANGUARD SHORT-TERM INVESTMENT GRADE FUND ADMIRAL SHRS
- Up to $250,000 in CHARLES SCHWABB IRA ⇒ VANGUARD S&P 500 ETF
You can see all their disclosed assets on the Quiver Quantitative politician page for Leger Fernandez.
You can track politicians' wealth on our live net worth tracker.
Representative Teresa Leger Fernandez Net Worth
Quiver Quantitative estimates that Representative Teresa Leger Fernandez is worth $2.1M, as of August 29th, 2025. This is the 249th highest net worth in Congress, per our live estimates.
Leger Fernandez has approximately $358.7K invested in publicly traded assets which Quiver is able to track live.
You can track Representative Teresa Leger Fernandez's net worth on Quiver Quantitative's politician page for Leger Fernandez.
Representative Teresa Leger Fernandez Stock Trading
We have data on up to $50.0K of trades from Representative Teresa Leger Fernandez, which we parsed from STOCK Act filings. Some of the largest trades include:
- A January 20th, 2021 sale of up to $50K of $GBDC. The stock has risen 1.75% since then.
You can track Representative Teresa Leger Fernandez's stock trading on Quiver Quantitative's politician page for Leger Fernandez.
Representative Teresa Leger Fernandez Bill Proposals
Here are some bills which have recently been proposed by Representative Teresa Leger Fernandez:
- H.R.4892: Seedlings for Sustainable Habitat Restoration Act of 2025
- H.R.4598: Technical Corrections to the Northwestern New Mexico Rural Water Projects Act, Taos Pueblo Indian Water Rights Settlement Act, and Aamodt Litigation Settlement Act
- H.R.4510: Healing Partnerships for Survivors Act
- H.R.4338: Weather-Safe Energy Act of 2025
- H.R.4284: Small Cemetery Conveyance Act
- H.R.3293: Support Water-Efficient Strategies and Technologies Act of 2025
You can track bills proposed by Representative Teresa Leger Fernandez on Quiver Quantitative's politician page for Leger Fernandez.
Representative Teresa Leger Fernandez Fundraising
Representative Teresa Leger Fernandez recently disclosed $185.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 459th most from all Q2 reports we have seen this year. 87.6% came from individual donors.
Leger Fernandez disclosed $162.9K of spending. This was the 342nd most from all Q2 reports we have seen from politicians so far this year.
Leger Fernandez disclosed $483.7K of cash on hand at the end of the filing period. This was the 476th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Teresa Leger Fernandez's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Senator Sheldon Whitehouse has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $5,000,000 in AAPL-Apple Inc.
- Up to $5,000,000 in NVDA-NVIDIA Corporation
- Up to $1,000,000 in AMZN-Amazon.com Inc. (NASDAQ)
- Up to $1,000,000 in MSFT-Microsoft Corporation (NASDAQ)
- Up to $1,000,000 in NVDA - NVIDIA Corporation - Common Stock
You can see all their disclosed assets on the Quiver Quantitative politician page for Whitehouse.
You can track politicians' wealth on our live net worth tracker.
Senator Sheldon Whitehouse Net Worth
Quiver Quantitative estimates that Senator Sheldon Whitehouse is worth $23.5M, as of August 29th, 2025. This is the 54th highest net worth in Congress, per our live estimates.
Whitehouse has approximately $20.8M invested in publicly traded assets which Quiver is able to track live.
You can track Senator Sheldon Whitehouse's net worth on Quiver Quantitative's politician page for Whitehouse.
Senator Sheldon Whitehouse Stock Trading
We have data on up to $24.0M of trades from Senator Sheldon Whitehouse, which we parsed from STOCK Act filings. Some of the largest trades include:
- A October 28th, 2024 sale of up to $250K of $TSLA. The stock has risen 27.99% since then.
- A November 16th, 2023 sale of up to $100K of $KMB. The stock has risen 6.31% since then.
- A May 27th, 2015 sale of up to $50K of $TU. The stock has fallen 3.19% since then.
- A December 3rd, 2018 sale of up to $50K of $BUD. The stock has fallen 17.59% since then.
- A February 12th, 2019 sale of up to $50K of $HAS. The stock has fallen 9.65% since then.
You can track Senator Sheldon Whitehouse's stock trading on Quiver Quantitative's politician page for Whitehouse.
Senator Sheldon Whitehouse Bill Proposals
Here are some bills which have recently been proposed by Senator Sheldon Whitehouse:
- S.2540: Comprehensive Addiction and Recovery Justice Grant Reauthorization Act
- S.2533: Pick Up After Your DOGE Act
- S.2402: First-Time Homebuyer Tax Credit Act of 2025
- S.2344: Department of Veterans Affairs Claim Sharks Effective Warnings Act of 2025
- S.2243: International Maritime Pollution Accountability Act of 2025
- S.2235: Diesel Emissions Reduction Act of 2025
You can track bills proposed by Senator Sheldon Whitehouse on Quiver Quantitative's politician page for Whitehouse.
Senator Sheldon Whitehouse Fundraising
Senator Sheldon Whitehouse recently disclosed $77.5K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 659th most from all Q2 reports we have seen this year. 88.7% came from individual donors.
Whitehouse disclosed $91.1K of spending. This was the 535th most from all Q2 reports we have seen from politicians so far this year.
Whitehouse disclosed $1.2M of cash on hand at the end of the filing period. This was the 261st most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Senator Sheldon Whitehouse's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Jake Ellzey has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $5,000,000 in FIRSTBANK SOUTHWEST CERTIFICATES OF DEPOSIT
- Up to $5,000,000 in INHERITED HOUSE
- Up to $1,000,000 in ELLIS FAMILY TRUST ⇒ FIRST PERRYTON BANCORP, INC.
- Up to $500,000 in SOUTHWEST AIRLINES PILOTS ASSOCIATION RETIREMENT SAVINGS PLAN ⇒ AMERICAN FUNDS 2035 TARGET DATE RETIREMENT FD CL R-6
- Up to $250,000 in ELLIS FAMILY TRUST ⇒ FIRSTBANK SOUTHWEST MONEY MARKET ACCOUNT
You can see all their disclosed assets on the Quiver Quantitative politician page for Ellzey.
You can track politicians' wealth on our live net worth tracker.
Representative Jake Ellzey Net Worth
Quiver Quantitative estimates that Representative Jake Ellzey is worth $8.8M, as of August 29th, 2025. This is the 118th highest net worth in Congress, per our live estimates.
Ellzey has approximately $0 invested in publicly traded assets which Quiver is able to track live.
You can track Representative Jake Ellzey's net worth on Quiver Quantitative's politician page for Ellzey.
Representative Jake Ellzey Bill Proposals
Here are some bills which have recently been proposed by Representative Jake Ellzey:
- H.R.4845: To designate the National Memorial Day Parade, and for other purposes.
- H.R.3871: Apprenticeship Infrastructure Tax Credit Act of 2025
You can track bills proposed by Representative Jake Ellzey on Quiver Quantitative's politician page for Ellzey.
Representative Jake Ellzey Fundraising
Representative Jake Ellzey recently disclosed $479.8K of fundraising in a Q2 FEC disclosure filed on July 15th, 2025. This was the 168th most from all Q2 reports we have seen this year. 74.2% came from individual donors.
Ellzey disclosed $571.0K of spending. This was the 75th most from all Q2 reports we have seen from politicians so far this year.
Ellzey disclosed $1.9M of cash on hand at the end of the filing period. This was the 165th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Jake Ellzey's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Representative Mike Kennedy has filed a new annual financial disclosure, which was parsed by Quiver's congressional net worth tracking software.
Some of the disclosed holdings which were parsed include:
- Up to $500,000 in KENNEDY FOR US SENATE
- Up to $250,000 in FIDELITY INVESTMENTS ⇒ UUHC 401A ⇒ FID FRDM BLND 2035
- Up to $250,000 in MICHAEL KENNEDY, MD, INC. ⇒ PREMIER FAMILY MEDICAL, LLC
- Up to $250,000 in MIKE KENNEDY FOR UTAH
- Up to $100,000 in ALTA CHECKING ACCOUNT
You can see all their disclosed assets on the Quiver Quantitative politician page for Kennedy.
You can track politicians' wealth on our live net worth tracker.
Representative Mike Kennedy Net Worth
Quiver Quantitative estimates that Representative Mike Kennedy is worth $1.4M, as of August 29th, 2025. This is the 291st highest net worth in Congress, per our live estimates.
Kennedy has approximately $24.0K invested in publicly traded assets which Quiver is able to track live.
You can track Representative Mike Kennedy's net worth on Quiver Quantitative's politician page for Kennedy.
Representative Mike Kennedy Stock Trading
We have data on up to $15.0K of trades from Representative Mike Kennedy, which we parsed from STOCK Act filings. Some of the largest trades include:
- A May 9th, 2025 purchase of up to $15K of $BRK.B. The stock has fallen 1.77% since then.
You can track Representative Mike Kennedy's stock trading on Quiver Quantitative's politician page for Kennedy.
Representative Mike Kennedy Bill Proposals
Here are some bills which have recently been proposed by Representative Mike Kennedy:
- H.R.4952: Ensuring Coast Guard Readiness Act
- H.R.4951: Ensuring Naval Readiness Act
- H.R.4684: Star-Spangled Summit Act of 2025
- H.R.3595: Safe Prescribing Through Reporting Act of 2025
- H.R.3451: To amend the National Trails System Act to direct the Secretary of the Interior to conduct a study on the feasibility of designating the Bonneville Shoreline Trail.
- H.R.3425: POST Act of 2025
You can track bills proposed by Representative Mike Kennedy on Quiver Quantitative's politician page for Kennedy.
Representative Mike Kennedy Fundraising
Representative Mike Kennedy recently disclosed $0 of fundraising in a Q2 FEC disclosure filed on July 2nd, 2025. This was the 1178th most from all Q2 reports we have seen this year. nan% came from individual donors.
Kennedy disclosed $0.0 of spending. This was the 1580th most from all Q2 reports we have seen from politicians so far this year.
Kennedy disclosed $0 of cash on hand at the end of the filing period. This was the 1909th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Representative Mike Kennedy's fundraising on Quiver Quantitative.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
Scott D Ehrig, the SVP of $FRAF, sold 1,060 shares of the company on 08-27-2025 for an estimated $49,639. We received data on the trade from a recent SEC filing. This was a sale of approximately 35.3% of their shares of this class of stock. Following this trade, they now own 1,942 shares of this class of $FRAF stock.
$FRAF Insider Trading Activity
$FRAF insiders have traded $FRAF stock on the open market 12 times in the past 6 months. Of those trades, 7 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $FRAF stock by insiders over the last 6 months:
- CRAIG W BEST (President) purchased 6,756 shares for an estimated $249,972
- SCOTT D EHRIG (SVP, Chief Wealth Officer) sold 1,060 shares for an estimated $49,639
- STEVEN D BUTZ (SVP, CCSO) sold 998 shares for an estimated $38,742
- CHARLES BENNER JR CARROLL (EVP, COO) sold 650 shares for an estimated $30,257
- MARK R HOLLAR (EVP/CFO) sold 179 shares for an estimated $8,368
- MATTHEW D WEAVER (SVP, Chief Marketing Officer) purchased 186 shares for an estimated $7,010
- DAVID M LONG (SVP, Chief Technology Officer) sold 137 shares for an estimated $6,069
- GREGORY A DUFFEY has made 2 purchases buying 51 shares for an estimated $2,015 and 0 sales.
- KAREN K CARMACK (SVP, Chief HR Officer) has made 3 purchases buying 3 shares for an estimated $113 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$FRAF Hedge Fund Activity
We have seen 36 institutional investors add shares of $FRAF stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 166,901 shares (+598.8%) to their portfolio in Q2 2025, for an estimated $5,778,947
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 64,886 shares (-90.9%) from their portfolio in Q2 2025, for an estimated $2,246,677
- GEODE CAPITAL MANAGEMENT, LLC added 51,407 shares (+109.8%) to their portfolio in Q2 2025, for an estimated $1,779,967
- MILLENNIUM MANAGEMENT LLC removed 40,391 shares (-73.3%) from their portfolio in Q2 2025, for an estimated $1,398,538
- MARSHALL WACE, LLP added 34,982 shares (+333.6%) to their portfolio in Q2 2025, for an estimated $1,211,251
- FARMERS & MERCHANTS TRUST CO OF CHAMBERSBURG PA removed 33,003 shares (-96.8%) from their portfolio in Q2 2025, for an estimated $1,142,728
- VANGUARD GROUP INC added 31,003 shares (+15.9%) to their portfolio in Q2 2025, for an estimated $1,073,478
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
Recent discussions on X about Houlihan Lokey (HLI) have centered around the stock's impressive performance and technical indicators. Posts highlight a notable breakout in the stock's price pattern, with some pointing to supportive volume trends and a strong base formation as signs of potential upward momentum. This buzz comes alongside news of the company reaching a new 52-week high, fueling further interest among market watchers.
Additionally, there’s chatter about institutional investments, with several large funds reportedly increasing their stakes in HLI, as noted in recent financial filings shared on the platform. The stock's long-term performance, including significant returns over the past decade, has also been a topic of conversation, with some users marveling at its consistent outperformance compared to broader market indices. These discussions reflect a keen focus on both technical and fundamental aspects of the company’s trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
Houlihan Lokey Congressional Stock Trading
Members of Congress have traded $HLI stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $HLI stock by members of Congress over the last 6 months:
- REPRESENTATIVE KELLY MORRISON sold up to $15,000 on 06/04.
- REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 04/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Houlihan Lokey Insider Trading Activity
Houlihan Lokey insiders have traded $HLI stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $HLI stock by insiders over the last 6 months:
- PAUL ERIC SIEGERT (CO-CHAIRMAN) sold 40,000 shares for an estimated $7,998,000
- SCOTT L BEISER (CO-CHAIRMAN) sold 8,008 shares for an estimated $1,431,109
- IRWIN GOLD (CO-CHAIRMAN) sold 5,000 shares for an estimated $914,050
- GILLIAN BETH ZUCKER has made 0 purchases and 5 sales selling 1,000 shares for an estimated $171,432.
- CHRISTOPHER M CRAIN (GENERAL COUNSEL) sold 500 shares for an estimated $86,510
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Houlihan Lokey Hedge Fund Activity
We have seen 261 institutional investors add shares of Houlihan Lokey stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 681,657 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $122,664,177
- CHAMPLAIN INVESTMENT PARTNERS, LLC added 361,085 shares (+194.9%) to their portfolio in Q2 2025, for an estimated $64,977,245
- THRIVENT FINANCIAL FOR LUTHERANS removed 353,812 shares (-98.4%) from their portfolio in Q2 2025, for an estimated $63,668,469
- CAPITAL RESEARCH GLOBAL INVESTORS added 294,781 shares (+58.5%) to their portfolio in Q2 2025, for an estimated $53,045,840
- PRUDENTIAL FINANCIAL INC removed 266,988 shares (-76.8%) from their portfolio in Q1 2025, for an estimated $43,118,562
- RENAISSANCE GROUP LLC added 189,583 shares (+inf%) to their portfolio in Q2 2025, for an estimated $34,115,460
- ASSENAGON ASSET MANAGEMENT S.A. added 182,729 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,882,083
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Houlihan Lokey Government Contracts
We have seen $24,903 of award payments to $HLI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Houlihan Lokey Analyst Ratings
Wall Street analysts have issued reports on $HLI in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/14/2025
- Wells Fargo issued a "Overweight" rating on 07/11/2025
- Morgan Stanley issued a "Overweight" rating on 06/23/2025
To track analyst ratings and price targets for Houlihan Lokey, check out Quiver Quantitative's $HLI forecast page.
Houlihan Lokey Price Targets
Multiple analysts have issued price targets for $HLI recently. We have seen 4 analysts offer price targets for $HLI in the last 6 months, with a median target of $200.5.
Here are some recent targets:
- Alex Bond from Keefe, Bruyette & Woods set a target price of $232.0 on 07/14/2025
- Michael Brown from Wells Fargo set a target price of $209.0 on 07/11/2025
- Ryan Kenny from Morgan Stanley set a target price of $192.0 on 06/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent chatter on X about Amazon (AMZN) has been buzzing with reactions to the company's latest streaming partnership and AI investment plans. Many users are intrigued by how these developments could bolster Amazon's growth, particularly in its AWS segment, though some express concern over the heavy capital expenditure required. The conversation reflects a mix of optimism and caution as investors weigh the potential long-term benefits against short-term financial pressures.
Additionally, posts on X highlight Amazon's strategic moves in retail and cloud computing as key drivers of sentiment, with some users pointing to a perceived lag in AI advancements compared to competitors. Discussions often circle back to the stock's recent performance, with a notable focus on whether upcoming earnings will validate these ambitious initiatives. The tone on the platform remains dynamic, with fervent debates over the sustainability of Amazon's growth trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
Amazon Congressional Stock Trading
Members of Congress have traded $AMZN stock 40 times in the past 6 months. Of those trades, 28 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $AMZN stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 4 times. They made 2 purchases worth up to $30,000 on 06/17, 06/09 and 2 sales worth up to $30,000 on 08/04, 07/22.
- REPRESENTATIVE CLEO FIELDS has traded it 10 times. They made 10 purchases worth up to $2,115,000 on 07/29, 07/16, 07/14, 06/30, 06/25, 06/09, 06/05 and 0 sales.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 04/08 and 2 sales worth up to $30,000 on 06/23, 04/03.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 05/16.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $500,000 on 05/12.
- REPRESENTATIVE THOMAS H. KEAN, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/08, 04/24 and 0 sales.
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $45,000 on 05/05, 04/08, 04/04 and 0 sales.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 04/29.
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 4 times. They made 3 purchases worth up to $45,000 on 04/23, 03/24, 03/03 and 1 sale worth up to $50,000 on 04/16.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 3 times. They made 1 purchase worth up to $50,000 on 03/03 and 2 sales worth up to $30,000 on 04/21, 03/20.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $50,000 on 04/07.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 04/03.
- REPRESENTATIVE DAVID TAYLOR purchased up to $15,000 on 03/27.
- REPRESENTATIVE GREG LANDSMAN sold up to $15,000 on 03/27.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/20 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Amazon Insider Trading Activity
Amazon insiders have traded $AMZN stock on the open market 66 times in the past 6 months. Of those trades, 0 have been purchases and 66 have been sales.
Here’s a breakdown of recent trading of $AMZN stock by insiders over the last 6 months:
- JEFFREY P BEZOS (Executive Chair) has made 0 purchases and 22 sales selling 25,000,000 shares for an estimated $5,654,270,933.
- DAVID ZAPOLSKY (Senior Vice President) has made 0 purchases and 8 sales selling 41,340 shares for an estimated $8,771,239.
- ANDREW R JASSY (President and CEO) has made 0 purchases and 5 sales selling 39,744 shares for an estimated $8,403,578.
- MATTHEW S GARMAN (CEO Amazon Web Services) has made 0 purchases and 6 sales selling 38,708 shares for an estimated $8,152,467.
- DOUGLAS J HERRINGTON (CEO Worldwide Amazon Stores) has made 0 purchases and 18 sales selling 35,746 shares for an estimated $7,595,708.
- BRIAN T OLSAVSKY (Senior Vice President and CFO) has made 0 purchases and 2 sales selling 35,500 shares for an estimated $7,531,502.
- SHELLEY REYNOLDS (Vice President) has made 0 purchases and 4 sales selling 5,410 shares for an estimated $1,142,883.
- KEITH BRIAN ALEXANDER sold 1,000 shares for an estimated $210,680
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Amazon Hedge Fund Activity
We have seen 3,048 institutional investors add shares of Amazon stock to their portfolio, and 2,203 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 132,616,953 shares (+542733.6%) to their portfolio in Q2 2025, for an estimated $29,094,833,318
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 69,080,235 shares (+781.6%) to their portfolio in Q2 2025, for an estimated $15,155,512,756
- GAMMA INVESTING LLC removed 30,063,218 shares (-99.4%) from their portfolio in Q2 2025, for an estimated $6,595,569,397
- INFINITUM ASSET MANAGEMENT, LLC removed 23,657,500 shares (-99.5%) from their portfolio in Q2 2025, for an estimated $5,190,218,925
- VANGUARD GROUP INC added 17,447,045 shares (+2.1%) to their portfolio in Q2 2025, for an estimated $3,827,707,202
- PRICE T ROWE ASSOCIATES INC /MD/ removed 17,284,407 shares (-9.8%) from their portfolio in Q2 2025, for an estimated $3,792,026,051
- CAPITAL WORLD INVESTORS removed 16,381,890 shares (-24.7%) from their portfolio in Q2 2025, for an estimated $3,594,022,847
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Amazon Analyst Ratings
Wall Street analysts have issued reports on $AMZN in the last several months. We have seen 34 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 08/14/2025
- Telsey Advisory Group issued a "Outperform" rating on 08/13/2025
- Evercore ISI Group issued a "Outperform" rating on 08/13/2025
- Oppenheimer issued a "Outperform" rating on 08/01/2025
- B of A Securities issued a "Buy" rating on 08/01/2025
- JP Morgan issued a "Overweight" rating on 08/01/2025
- Canaccord Genuity issued a "Buy" rating on 08/01/2025
To track analyst ratings and price targets for Amazon, check out Quiver Quantitative's $AMZN forecast page.
Amazon Price Targets
Multiple analysts have issued price targets for $AMZN recently. We have seen 37 analysts offer price targets for $AMZN in the last 6 months, with a median target of $265.0.
Here are some recent targets:
- Brian Nowak from Morgan Stanley set a target price of $300.0 on 08/14/2025
- Mark Mahaney from Evercore ISI Group set a target price of $280.0 on 08/13/2025
- Joseph Feldman from Telsey Advisory Group set a target price of $265.0 on 08/13/2025
- Mark Kelley from Stifel set a target price of $260.0 on 08/01/2025
- Laura Martin from Needham set a target price of $265.0 on 08/01/2025
- Deepak Mathivanan from Cantor Fitzgerald set a target price of $280.0 on 08/01/2025
- Shyam Patil from Susquehanna set a target price of $260.0 on 08/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Marvell Technology (MRVL) have centered around the company's latest quarterly earnings report and its disappointing third-quarter revenue outlook. Many users expressed concern over the reported weakness in data center demand, particularly with custom AI chips, which led to a significant premarket drop in the stock price. The sentiment reflects a sense of unease as investors grapple with the gap between high expectations and the company's guidance.
Despite a robust year-over-year revenue increase of nearly 58%, fueled by strong data center sales, the mood on X remains cautious due to broader sector challenges like economic uncertainty and potential tariff impacts. Some users highlighted Marvell's deep collaborations with major tech giants as a potential long-term strength, sparking a mix of hope and skepticism. The conversation continues to evolve as analysts and investors digest the implications of the latest financials.
Note: This discussion summary was generated from an AI condensation of post data.
Marvell Technology Congressional Stock Trading
Members of Congress have traded $MRVL stock 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $MRVL stock by members of Congress over the last 6 months:
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
- REPRESENTATIVE RITCHIE TORRES has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/06 and 1 sale worth up to $15,000 on 07/11.
- REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 4 times. They made 1 purchase worth up to $100,000 on 04/07 and 3 sales worth up to $200,000 on 05/12, 05/08, 03/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Marvell Technology Insider Trading Activity
Marvell Technology insiders have traded $MRVL stock on the open market 15 times in the past 6 months. Of those trades, 1 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $MRVL stock by insiders over the last 6 months:
- CHRIS KOOPMANS (Chief Operating Officer) has made 0 purchases and 3 sales selling 18,000 shares for an estimated $1,193,580.
- MARK CASPER (EVP & Chief Legal Officer) has made 0 purchases and 3 sales selling 16,086 shares for an estimated $940,598.
- WILLEM A MEINTJES (Chief Financial Officer) has made 0 purchases and 4 sales selling 6,000 shares for an estimated $393,150.
- PANTEHA DIXON (Chief Accounting Officer) has made 0 purchases and 4 sales selling 5,238 shares for an estimated $350,335.
- BRAD W BUSS purchased 3,000 shares for an estimated $207,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Marvell Technology Hedge Fund Activity
We have seen 771 institutional investors add shares of Marvell Technology stock to their portfolio, and 760 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 17,244,465 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,334,721,591
- FMR LLC removed 9,026,726 shares (-7.3%) from their portfolio in Q2 2025, for an estimated $698,668,592
- GOLDMAN SACHS GROUP INC removed 7,924,625 shares (-38.4%) from their portfolio in Q2 2025, for an estimated $613,365,975
- GQG PARTNERS LLC removed 7,264,921 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $447,301,185
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,902,182 shares (+89.6%) to their portfolio in Q2 2025, for an estimated $534,228,886
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 6,891,393 shares (+4758.5%) to their portfolio in Q2 2025, for an estimated $533,393,818
- FIL LTD added 6,446,067 shares (+253.1%) to their portfolio in Q2 2025, for an estimated $498,925,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Marvell Technology Analyst Ratings
Wall Street analysts have issued reports on $MRVL in the last several months. We have seen 19 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/29/2025
- UBS issued a "Buy" rating on 08/29/2025
- Benchmark issued a "Buy" rating on 08/29/2025
- Evercore ISI Group issued a "Outperform" rating on 08/29/2025
- Oppenheimer issued a "Outperform" rating on 08/29/2025
- Needham issued a "Buy" rating on 08/29/2025
- Rosenblatt issued a "Buy" rating on 08/29/2025
To track analyst ratings and price targets for Marvell Technology, check out Quiver Quantitative's $MRVL forecast page.
Marvell Technology Price Targets
Multiple analysts have issued price targets for $MRVL recently. We have seen 26 analysts offer price targets for $MRVL in the last 6 months, with a median target of $87.5.
Here are some recent targets:
- Aaron Rakers from Wells Fargo set a target price of $90.0 on 08/29/2025
- Thomas O'Malley from Barclays set a target price of $80.0 on 08/29/2025
- Joseph Moore from Morgan Stanley set a target price of $76.0 on 08/29/2025
- Timothy Arcuri from UBS set a target price of $95.0 on 08/29/2025
- Cody Acree from Benchmark set a target price of $95.0 on 08/29/2025
- Mark Lipacis from Evercore ISI Group set a target price of $122.0 on 08/29/2025
- Vivek Arya from B of A Securities set a target price of $78.0 on 08/29/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about GameStop (GME) have been fueled by the company's latest strategic moves, including talks of a significant capital raise and potential Bitcoin investment initiatives. Many users are dissecting how these developments could reshape the company’s financial landscape, with some expressing optimism about the potential for growth in new digital arenas. The stock’s notorious volatility continues to captivate attention, keeping the conversation lively and speculative.
Additionally, there’s a notable buzz around GameStop’s upcoming Q2 earnings, with some on X pointing to technical indicators suggesting a potential sharp price movement. Debates are ongoing about whether the stock’s current price reflects its fundamental strengths, with a few voices highlighting the company’s cash reserves as a key point of confidence. This mix of anticipation and analysis keeps the GameStop narrative dynamic on the platform.
Note: This discussion summary was generated from an AI condensation of post data.
GameStop Congressional Stock Trading
Members of Congress have traded $GME stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GME stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
GameStop Insider Trading Activity
GameStop insiders have traded $GME stock on the open market 10 times in the past 6 months. Of those trades, 4 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $GME stock by insiders over the last 6 months:
- RYAN COHEN (President, CEO and Chairman) purchased 500,000 shares for an estimated $10,775,000
- MARK HAYMOND ROBINSON (General Counsel and Secretary) has made 0 purchases and 4 sales selling 17,041 shares for an estimated $404,015.
- ALAIN ATTAL purchased 10,000 shares for an estimated $257,500
- JAMES GRUBE purchased 5,575 shares for an estimated $132,183
- LAWRENCE CHENG purchased 5,000 shares for an estimated $107,700
- DANIEL WILLIAM MOORE (PFO and PAO) has made 0 purchases and 2 sales selling 2,329 shares for an estimated $53,494.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GameStop Hedge Fund Activity
We have seen 183 institutional investors add shares of GameStop stock to their portfolio, and 179 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP added 5,170,741 shares (+347.7%) to their portfolio in Q2 2025, for an estimated $126,114,372
- INVESCO LTD. added 3,200,321 shares (+486.6%) to their portfolio in Q2 2025, for an estimated $78,055,829
- GOLDMAN SACHS GROUP INC added 3,156,461 shares (+1204.1%) to their portfolio in Q2 2025, for an estimated $76,986,083
- NORGES BANK added 3,080,586 shares (+4799.3%) to their portfolio in Q2 2025, for an estimated $75,135,492
- CLEAR STREET LLC added 2,354,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $57,433,059
- CITADEL ADVISORS LLC added 2,173,746 shares (+78.4%) to their portfolio in Q2 2025, for an estimated $53,017,664
- BANK OF MONTREAL /CAN/ added 2,136,926 shares (+1673.5%) to their portfolio in Q2 2025, for an estimated $52,119,625
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GameStop Analyst Ratings
Wall Street analysts have issued reports on $GME in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Underperform" rating on 06/11/2025
To track analyst ratings and price targets for GameStop, check out Quiver Quantitative's $GME forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Microsoft (MSFT) have been buzzing with reactions to the company's latest earnings report and its heavy investments in AI and cloud computing. Many users are captivated by the reported 16% year-over-year revenue growth, particularly driven by the robust performance of Azure, which some see as a cornerstone of future growth. The excitement is tempered, however, by concerns over stock volatility, with a notable 10% drop since July highs sparking debate over whether this is a temporary pullback or a sign of deeper challenges.
Additionally, posts on X reflect intrigue around Microsoft’s strategic moves, including its AI initiatives and whispers of potential stock splits, given the current high share price. Some users are optimistic, pointing to the company’s fundamentals and Azure’s competitive edge as reasons for confidence, while others caution against over-enthusiasm amid broader market headwinds. The conversation remains dynamic, with the stock hovering near key support levels as observers watch for the next catalyst.
Note: This discussion summary was generated from an AI condensation of post data.
Microsoft Congressional Stock Trading
Members of Congress have traded $MSFT stock 48 times in the past 6 months. Of those trades, 24 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $MSFT stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS has traded it 9 times. They made 9 purchases worth up to $1,415,000 on 07/29, 07/28, 07/16, 06/25, 06/03 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON has traded it 4 times. They made 0 purchases and 4 sales worth up to $95,000 on 07/29, 04/07, 04/01.
- SENATOR ANGUS S. KING JR. purchased up to $15,000 on 07/21.
- SENATOR SHELLEY MOORE CAPITO has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/18, 06/18.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $65,000 on 07/16, 06/09 and 1 sale worth up to $15,000 on 06/11.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE JOHN W. ROSE sold up to $500,000 on 06/03.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/22, 05/21 and 0 sales.
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 05/13, 05/12.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $1,000,000 on 05/08 and 2 sales worth up to $1,500,000 on 05/12, 04/07.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 4 purchases worth up to $95,000 on 05/09, 04/08, 04/03 and 0 sales.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/29 and 1 sale worth up to $50,000 on 03/31.
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 04/22, 04/16 and 0 sales.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 3 times. They made 1 purchase worth up to $50,000 on 03/03 and 2 sales worth up to $65,000 on 04/21, 03/20.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE JONATHAN L. JACKSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $115,000 on 04/10, 03/04.
- REPRESENTATIVE GREG LANDSMAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $200,000 on 03/27.
- REPRESENTATIVE GEORGE WHITESIDES sold up to $500,000 on 03/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Microsoft Insider Trading Activity
Microsoft insiders have traded $MSFT stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $MSFT stock by insiders over the last 6 months:
- BRADFORD L SMITH (Vice Chair and President) has made 0 purchases and 3 sales selling 81,000 shares for an estimated $35,302,944.
- KATHLEEN T HOGAN (EVP, Strategy) sold 21,500 shares for an estimated $9,756,151
- JUDSON ALTHOFF (EVP, Chief Commercial Officer) has made 0 purchases and 2 sales selling 16,000 shares for an estimated $7,330,817.
- AMY COLEMAN (EVP, Chief Human Resources Off) sold 13,242 shares for an estimated $5,985,886
- TAKESHI NUMOTO (EVP, Chief Marketing Officer) has made 0 purchases and 4 sales selling 8,850 shares for an estimated $4,406,514.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Microsoft Hedge Fund Activity
We have seen 2,725 institutional investors add shares of Microsoft stock to their portfolio, and 2,818 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 90,533,328 shares (+564387.1%) to their portfolio in Q2 2025, for an estimated $45,032,182,680
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 52,343,132 shares (-84.1%) from their portfolio in Q2 2025, for an estimated $26,035,997,288
- GAMMA INVESTING LLC removed 46,539,719 shares (-99.7%) from their portfolio in Q2 2025, for an estimated $23,149,321,627
- JPMORGAN CHASE & CO added 15,048,970 shares (+10.6%) to their portfolio in Q2 2025, for an estimated $7,485,508,167
- VANGUARD GROUP INC added 13,691,572 shares (+2.0%) to their portfolio in Q2 2025, for an estimated $6,810,324,828
- FMR LLC added 10,348,184 shares (+5.3%) to their portfolio in Q2 2025, for an estimated $5,147,290,203
- AMUNDI removed 7,227,353 shares (-18.4%) from their portfolio in Q2 2025, for an estimated $3,594,957,655
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Microsoft Government Contracts
We have seen $397,092,251 of award payments to $MSFT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- MICROSOFT CONSULTING SERVICES (MCS) AND MICROSOFT PREMIER SUPPORT (MPS) FOR THE UNITED STATES MARINE CORPS ...: $54,072,416
- MICROSOFT CONSULTING SERVICES (MCS) AND UNIFIED SUPPORT FOR THE U.S. NAVY / PROGRAM EXECUTIVE OFFICE DIGITA...: $36,429,433
- MICROSOFT AZURE STRATUS HSTXXX0000002144 93A34F: $22,200,657
- ARMY CYBER COMMANDS MICROSOFT CONSULTING SERVICES AND MICROSOFT PREMIER SUPPORT: $21,679,735
- MICROSOFT ENTERPRISE TECHNICAL SOLUTIONS SERVICES (METSS) MICROSOFT CONSULTING SERVICES (MCS) AND MICROSOFT...: $20,137,899
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Microsoft Analyst Ratings
Wall Street analysts have issued reports on $MSFT in the last several months. We have seen 27 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 08/29/2025
- Truist Securities issued a "Buy" rating on 08/18/2025
- RBC Capital issued a "Outperform" rating on 07/31/2025
- Cantor Fitzgerald issued a "Overweight" rating on 07/31/2025
- Wells Fargo issued a "Overweight" rating on 07/31/2025
- Keybanc issued a "Overweight" rating on 07/31/2025
- B of A Securities issued a "Buy" rating on 07/31/2025
To track analyst ratings and price targets for Microsoft, check out Quiver Quantitative's $MSFT forecast page.
Microsoft Price Targets
Multiple analysts have issued price targets for $MSFT recently. We have seen 27 analysts offer price targets for $MSFT in the last 6 months, with a median target of $625.0.
Here are some recent targets:
- Raimo Lenschow from Barclays set a target price of $625.0 on 08/29/2025
- Terry Tillman from Truist Securities set a target price of $675.0 on 08/18/2025
- Rishi Jaluria from RBC Capital set a target price of $640.0 on 07/31/2025
- Patrick Colville from Scotiabank set a target price of $650.0 on 07/31/2025
- Brad Sills from B of A Securities set a target price of $640.0 on 07/31/2025
- Jackson Ader from Keybanc set a target price of $630.0 on 07/31/2025
- Brian Schwartz from Oppenheimer set a target price of $630.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Oracle Corporation (ORCL) have centered around the company's strong performance in the AI and cloud computing sectors. Posts on the platform highlight a significant surge in stock value, with some noting a rise of over 60% in the past year, driven by bullish analyst predictions and strategic integrations of AI technologies. The buzz also includes anticipation for upcoming earnings, with many curious about whether the momentum will hold.
Another focal point on X is Oracle's cloud infrastructure growth, with users pointing to impressive year-over-year revenue increases and major deals as signs of robust demand. Some have expressed optimism about the company's raised revenue guidance and its competitive edge against other tech giants in the cloud space. These conversations reflect a dynamic interest in how Oracle is positioning itself for future growth amid rapid industry shifts.
Note: This discussion summary was generated from an AI condensation of post data.
Oracle Corporation Congressional Stock Trading
Members of Congress have traded $ORCL stock 13 times in the past 6 months. Of those trades, 6 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by members of Congress over the last 6 months:
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 4 times. They made 2 purchases worth up to $100,000 on 05/08, 03/05 and 2 sales worth up to $100,000 on 05/12, 04/07.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 04/16.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 04/08, 03/11.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 04/07.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Oracle Corporation Insider Trading Activity
Oracle Corporation insiders have traded $ORCL stock on the open market 43 times in the past 6 months. Of those trades, 1 have been purchases and 42 have been sales.
Here’s a breakdown of recent trading of $ORCL stock by insiders over the last 6 months:
- SAFRA CATZ (Chief Executive Officer) has made 0 purchases and 31 sales selling 8,694,918 shares for an estimated $1,825,887,891.
- JEFFREY HENLEY (Vice Chairman) has made 0 purchases and 2 sales selling 400,000 shares for an estimated $76,169,016.
- MICHAEL D. SICILIA (President, Industries) sold 15,880 shares for an estimated $4,041,142
- LEON E PANETTA has made 0 purchases and 2 sales selling 22,500 shares for an estimated $3,295,501.
- CLAYTON M. MAGOUYRK (President, OCI) sold 15,000 shares for an estimated $3,211,483
- MARIA SMITH (EVP, Chief Accounting Officer) sold 10,000 shares for an estimated $2,329,897
- GEORGE H CONRADES sold 8,169 shares for an estimated $1,743,999
- NAOMI O SELIGMAN has made 0 purchases and 3 sales selling 8,169 shares for an estimated $1,490,837.
- RONA ALISON FAIRHEAD purchased 480 shares for an estimated $112,257
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Oracle Corporation Hedge Fund Activity
We have seen 1,851 institutional investors add shares of Oracle Corporation stock to their portfolio, and 1,519 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FISHER ASSET MANAGEMENT, LLC removed 8,714,141 shares (-49.5%) from their portfolio in Q2 2025, for an estimated $1,905,172,646
- FMR LLC removed 7,143,518 shares (-22.3%) from their portfolio in Q2 2025, for an estimated $1,561,787,340
- NORGES BANK added 6,255,302 shares (+47.0%) to their portfolio in Q2 2025, for an estimated $1,367,596,676
- FRANKLIN RESOURCES INC removed 6,076,996 shares (-38.1%) from their portfolio in Q2 2025, for an estimated $1,328,613,635
- VICTORY CAPITAL MANAGEMENT INC added 5,925,776 shares (+683.5%) to their portfolio in Q2 2025, for an estimated $1,295,552,406
- AMUNDI removed 5,486,321 shares (-43.1%) from their portfolio in Q2 2025, for an estimated $1,199,474,360
- GAMMA INVESTING LLC removed 4,718,819 shares (-99.2%) from their portfolio in Q2 2025, for an estimated $1,031,675,397
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Oracle Corporation Government Contracts
We have seen $1,065,651,570 of award payments to $ORCL over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- OPTIMIZATION OF THE EHRM SYSTEM: $299,999,848
- IGF::OT::IGF TASK ORDER 36C10B18N0003 UNDER IDIQ CONTRACT 36C10B18D5000 FOR OPERATIONAL MANAGEMENT SERVICES...: $217,811,814
- EHRM OPERATIONS: $206,997,090
- EHRM LICENSES AND FEES: $97,806,309
- FORMALLY RECOGNIZE THE CONTRACTORS CORPORATE NAME CHANGE FROM CERNER GOVERNMENT SERVICES INC. TO ORACLE HEA...: $77,161,208
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Oracle Corporation Analyst Ratings
Wall Street analysts have issued reports on $ORCL in the last several months. We have seen 17 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 08/15/2025
- TD Cowen issued a "Buy" rating on 08/06/2025
- JMP Securities issued a "Market Outperform" rating on 07/18/2025
- Scotiabank issued a "Sector Outperform" rating on 07/17/2025
- UBS issued a "Buy" rating on 07/17/2025
- Piper Sandler issued a "Overweight" rating on 07/10/2025
- BMO Capital issued a "Outperform" rating on 07/02/2025
To track analyst ratings and price targets for Oracle Corporation, check out Quiver Quantitative's $ORCL forecast page.
Oracle Corporation Price Targets
Multiple analysts have issued price targets for $ORCL recently. We have seen 25 analysts offer price targets for $ORCL in the last 6 months, with a median target of $240.0.
Here are some recent targets:
- Siti Panigrahi from Mizuho set a target price of $300.0 on 08/15/2025
- Derrick Wood from TD Cowen set a target price of $325.0 on 08/06/2025
- Brad Sills from B of A Securities set a target price of $295.0 on 08/05/2025
- Patrick Walravens from JMP Securities set a target price of $315.0 on 07/18/2025
- Karl Keirstead from UBS set a target price of $280.0 on 07/17/2025
- Patrick Colville from Scotiabank set a target price of $300.0 on 07/17/2025
- Kirk Materne from Evercore ISI Group set a target price of $270.0 on 07/14/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent chatter on X about Opendoor Technologies (OPEN) has been intense, driven by a dramatic surge in stock price and significant leadership changes. Many users are captivated by the high trading volumes and technical patterns, with some expressing excitement over the stock's potential for further gains. Discussions often highlight the company's pivot towards AI and new strategic directions under interim leadership.
However, not all sentiments are uniformly positive, as some voices on X caution about the sustainability of this rally, pointing to concerns over fundamentals and market volatility. The stock's wild swings, including a reported drop of nearly 15% in a single day, have fueled debates about whether this is a genuine turnaround or a speculative frenzy. This polarized conversation keeps the ticker at the forefront of online financial discourse.
Note: This discussion summary was generated from an AI condensation of post data.
Opendoor Technologies Congressional Stock Trading
Members of Congress have traded $OPEN stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OPEN stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS purchased up to $15,000 on 07/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Opendoor Technologies Insider Trading Activity
Opendoor Technologies insiders have traded $OPEN stock on the open market 16 times in the past 6 months. Of those trades, 2 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $OPEN stock by insiders over the last 6 months:
- CARRIE WHEELER (Chief Executive Officer) has made 0 purchases and 3 sales selling 1,232,401 shares for an estimated $1,003,034.
- SYDNEY SCHAUB (Chief Legal Officer) has made 0 purchases and 11 sales selling 269,107 shares for an estimated $306,124.
- SHRISHA RADHAKRISHNA (President) has made 2 purchases buying 30,000 shares for an estimated $128,339 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Opendoor Technologies Hedge Fund Activity
We have seen 101 institutional investors add shares of Opendoor Technologies stock to their portfolio, and 195 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 35,718,664 shares (-70.2%) from their portfolio in Q2 2025, for an estimated $19,038,047
- VANGUARD GROUP INC removed 19,802,022 shares (-23.0%) from their portfolio in Q2 2025, for an estimated $10,554,477
- AMERICAN CENTURY COMPANIES INC removed 17,557,280 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,908,425
- QUBE RESEARCH & TECHNOLOGIES LTD added 12,540,603 shares (+inf%) to their portfolio in Q2 2025, for an estimated $6,684,141
- TWO SIGMA ADVISERS, LP added 11,260,300 shares (+616.7%) to their portfolio in Q2 2025, for an estimated $6,001,739
- WEISS ASSET MANAGEMENT LP added 9,606,779 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,120,413
- STATE STREET CORP removed 9,431,110 shares (-64.7%) from their portfolio in Q2 2025, for an estimated $5,026,781
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Opendoor Technologies Analyst Ratings
Wall Street analysts have issued reports on $OPEN in the last several months. We have seen 0 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Zelman & Assoc issued a "Underperform" rating on 08/07/2025
- Citigroup issued a "Sell" rating on 08/06/2025
To track analyst ratings and price targets for Opendoor Technologies, check out Quiver Quantitative's $OPEN forecast page.
Opendoor Technologies Price Targets
Multiple analysts have issued price targets for $OPEN recently. We have seen 4 analysts offer price targets for $OPEN in the last 6 months, with a median target of $1.0.
Here are some recent targets:
- Ryan Tomasello from Keefe, Bruyette & Woods set a target price of $1.0 on 08/13/2025
- An analyst from Zelman & Assoc set a target price of $1.0 on 08/07/2025
- Lloyd Walmsley from UBS set a target price of $1.6 on 08/06/2025
- Ygal Arounian from Citigroup set a target price of $0.7 on 08/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Summit Midstream Corporation (SMC) have been notably active, with a focus on the stock's performance and insider activity. Several posts highlight a significant insider buy reported above $20 per share, sparking interest among traders who see potential for a sharp upward movement. The low float of shares is frequently mentioned as a factor that could amplify price volatility.
Additionally, there is chatter about improved earnings and the stock reversing off its 52-week lows, fueling speculation about a possible rally. The sentiment on the platform appears to lean toward optimism, though some caution remains due to the stock's historical fluctuations. These discussions reflect a keen interest in SMC's near-term trajectory among retail investors.
Note: This discussion summary was generated from an AI condensation of post data.
Summit Midstream Corporation Insider Trading Activity
Summit Midstream Corporation insiders have traded $SMC stock on the open market 39 times in the past 6 months. Of those trades, 2 have been purchases and 37 have been sales.
Here’s a breakdown of recent trading of $SMC stock by insiders over the last 6 months:
- MIDSTREAM, LLC CONNECT has made 2 purchases buying 120,160 shares for an estimated $2,460,369 and 0 sales.
- J HEATH DENEKE (Chairman, President and CEO) has made 0 purchases and 34 sales selling 21,000 shares for an estimated $803,272.
- JERRY L PETERS has made 0 purchases and 3 sales selling 10,055 shares for an estimated $381,769.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Charles Schwab Corporation (SCHW) have centered around the company's stock performance following a notable pullback after a prolonged upward trend. Investors and commentators are actively debating whether this dip represents a temporary pause or signals deeper concerns about the firm's growth trajectory. Many are pointing to recent institutional activity, such as significant share purchases and sales by major funds, as a key factor influencing market sentiment.
Additionally, there’s chatter about insider trading activity, with some highlighting a major stock sale by a company director as a potential red flag, while others argue it’s a routine transaction unrelated to the firm's health. Posts on X also reflect curiosity about the impact of broader market conditions, like potential rate cuts, on Schwab’s future performance. The conversation remains dynamic, with opinions split on the stock’s near-term direction.
Note: This discussion summary was generated from an AI condensation of post data.
Charles Schwab Corporation Congressional Stock Trading
Members of Congress have traded $SCHW stock 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $SCHW stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/10 and 1 sale worth up to $15,000 on 07/16.
- REPRESENTATIVE RICK W. ALLEN purchased up to $50,000 on 07/10.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
- REPRESENTATIVE BRUCE WESTERMAN sold up to $15,000 on 04/21.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Charles Schwab Corporation Insider Trading Activity
Charles Schwab Corporation insiders have traded $SCHW stock on the open market 55 times in the past 6 months. Of those trades, 0 have been purchases and 55 have been sales.
Here’s a breakdown of recent trading of $SCHW stock by insiders over the last 6 months:
- CHARLES R. SCHWAB (Co-Chairman) has made 0 purchases and 7 sales selling 583,459 shares for an estimated $54,784,693.
- WALTER W BETTINGER (Co-Chairman) has made 0 purchases and 2 sales selling 365,399 shares for an estimated $34,231,822.
- CAROLYN SCHWAB-POMERANTZ has made 0 purchases and 18 sales selling 164,439 shares for an estimated $14,002,934.
- NIGEL J MURTAGH (Chief Risk Officer) has made 0 purchases and 5 sales selling 110,197 shares for an estimated $9,715,996.
- JONATHAN M. CRAIG (MD, Head of Investor Services) has made 0 purchases and 4 sales selling 108,985 shares for an estimated $9,017,447.
- PAUL V WOOLWAY (MD, Chief Banking Officer) has made 0 purchases and 12 sales selling 65,867 shares for an estimated $5,492,364.
- RICHARD A WURSTER (President & CEO) has made 0 purchases and 2 sales selling 35,845 shares for an estimated $3,323,039.
- PAULA A SNEED sold 8,647 shares for an estimated $761,479
- JONATHAN S BEATTY (MD, Head of Advisor Services) has made 0 purchases and 2 sales selling 6,508 shares for an estimated $560,502.
- CHARLES A. RUFFEL sold 5,556 shares for an estimated $486,986
- FRANK C HERRINGER sold 3,592 shares for an estimated $266,731
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Charles Schwab Corporation Hedge Fund Activity
We have seen 1,091 institutional investors add shares of Charles Schwab Corporation stock to their portfolio, and 980 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 19,534,868 shares (-95.3%) from their portfolio in Q2 2025, for an estimated $1,782,361,356
- JPMORGAN CHASE & CO added 16,444,010 shares (+30.4%) to their portfolio in Q2 2025, for an estimated $1,500,351,472
- PRICE T ROWE ASSOCIATES INC /MD/ removed 7,213,215 shares (-8.8%) from their portfolio in Q2 2025, for an estimated $658,133,736
- D. E. SHAW & CO., INC. removed 6,383,046 shares (-80.6%) from their portfolio in Q2 2025, for an estimated $582,389,117
- BROWN ADVISORY INC added 5,708,208 shares (+88.4%) to their portfolio in Q2 2025, for an estimated $520,816,897
- BLACKROCK, INC. added 5,353,480 shares (+4.4%) to their portfolio in Q2 2025, for an estimated $488,451,515
- MILLENNIUM MANAGEMENT LLC removed 5,058,101 shares (-73.9%) from their portfolio in Q2 2025, for an estimated $461,501,135
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Charles Schwab Corporation Analyst Ratings
Wall Street analysts have issued reports on $SCHW in the last several months. We have seen 12 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 08/15/2025
- Morgan Stanley issued a "Overweight" rating on 07/29/2025
- Citigroup issued a "Buy" rating on 07/21/2025
- Barclays issued a "Overweight" rating on 07/21/2025
- Keefe, Bruyette & Woods issued a "Outperform" rating on 07/21/2025
- Wells Fargo issued a "Overweight" rating on 07/11/2025
- Raymond James issued a "Outperform" rating on 07/09/2025
To track analyst ratings and price targets for Charles Schwab Corporation, check out Quiver Quantitative's $SCHW forecast page.
Charles Schwab Corporation Price Targets
Multiple analysts have issued price targets for $SCHW recently. We have seen 16 analysts offer price targets for $SCHW in the last 6 months, with a median target of $105.0.
Here are some recent targets:
- David Smith from Truist Securities set a target price of $112.0 on 08/15/2025
- Michael Cyprys from Morgan Stanley set a target price of $131.0 on 07/29/2025
- Devin Ryan from Citizens Capital Markets set a target price of $110.0 on 07/21/2025
- Kyle Voigt from Keefe, Bruyette & Woods set a target price of $108.0 on 07/21/2025
- Benjamin Budish from Barclays set a target price of $113.0 on 07/21/2025
- Craig Siegenthaler from B of A Securities set a target price of $84.0 on 07/21/2025
- Christopher Allen from Citigroup set a target price of $110.0 on 07/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent chatter on X about Alibaba Group Holding Limited (BABA) has centered on the company’s latest quarterly earnings report, released on August 29, 2025. Investors and analysts on the platform have highlighted the impressive growth in cloud and AI sectors, with some noting a triple-digit surge in AI-related sales as a key driver behind a roughly 9% spike in U.S. trading. However, concerns linger over weaker e-commerce performance and revenue shortfalls, sparking a mix of optimism and caution.
Additionally, posts on X have pointed to broader market dynamics, including China’s economic stimulus measures and a perceived reduction in regulatory risks, as potential tailwinds for BABA. Some users are optimistic about the company’s forward-looking strategy with custom AI chips, while others remain wary of competitive pressures in food delivery and ongoing softness in core commerce. The discussion reflects a complex outlook as the stock garners attention amid its 42% year-to-date rise.
Note: This discussion summary was generated from an AI condensation of post data.
Alibaba Group Holding Limited Congressional Stock Trading
Members of Congress have traded $BABA stock 6 times in the past 6 months. Of those trades, 4 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BABA stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 07/22, 06/09 and 1 sale worth up to $15,000 on 06/17.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 04/04.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $50,000 on 03/04.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Alibaba Group Holding Limited Hedge Fund Activity
We have seen 537 institutional investors add shares of Alibaba Group Holding Limited stock to their portfolio, and 815 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 49,010,087 shares (+1349768.3%) to their portfolio in Q2 2025, for an estimated $5,558,233,966
- FMR LLC removed 7,623,746 shares (-45.5%) from their portfolio in Q2 2025, for an estimated $864,609,033
- PRICE T ROWE ASSOCIATES INC /MD/ removed 7,478,315 shares (-87.0%) from their portfolio in Q2 2025, for an estimated $848,115,704
- BNP PARIBAS FINANCIAL MARKETS removed 7,199,005 shares (-88.5%) from their portfolio in Q2 2025, for an estimated $816,439,157
- BRIDGEWATER ASSOCIATES, LP removed 5,660,258 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $641,929,859
- FIL LTD removed 4,632,952 shares (-98.2%) from their portfolio in Q2 2025, for an estimated $525,423,086
- MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. removed 4,029,691 shares (-92.0%) from their portfolio in Q2 2025, for an estimated $457,007,256
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Alibaba Group Holding Limited Analyst Ratings
Wall Street analysts have issued reports on $BABA in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 07/15/2025
- B of A Securities issued a "Buy" rating on 07/11/2025
- Mizuho issued a "Outperform" rating on 05/16/2025
- Baird issued a "Outperform" rating on 05/16/2025
- Benchmark issued a "Buy" rating on 05/16/2025
- Citigroup issued a "Buy" rating on 04/08/2025
To track analyst ratings and price targets for Alibaba Group Holding Limited, check out Quiver Quantitative's $BABA forecast page.
Alibaba Group Holding Limited Price Targets
Multiple analysts have issued price targets for $BABA recently. We have seen 6 analysts offer price targets for $BABA in the last 6 months, with a median target of $152.5.
Here are some recent targets:
- Jiong Shao from Barclays set a target price of $145.0 on 07/15/2025
- Eddie Leung from B of A Securities set a target price of $135.0 on 07/11/2025
- James Lee from Mizuho set a target price of $160.0 on 05/16/2025
- Colin Sebastian from Baird set a target price of $142.0 on 05/16/2025
- Fawne Jiang from Benchmark set a target price of $176.0 on 05/16/2025
- Alicia Yap from Citigroup set a target price of $169.0 on 04/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Compass Minerals International (CMP) have centered around the company’s latest financial performance and a significant legal settlement. Posts on the platform highlight the fiscal 2025 third-quarter results, which showed a revenue increase to $214.6 million from $202.9 million year-over-year, sparking conversations about the company’s growth trajectory. Some users are optimistic, pointing to a 25% rise in adjusted EBITDA as a sign of operational strength.
Additionally, there’s buzz around a $1.4 million settlement of derivative actions, with X users debating the implications of the associated corporate governance reforms. While some see this as a step toward greater transparency, others question the long-term impact on investor confidence. The tone of these discussions varies, reflecting a mix of cautious hope and skepticism about the stock’s future.
Note: This discussion summary was generated from an AI condensation of post data.
Compass Minerals International Insider Trading Activity
Compass Minerals International insiders have traded $CMP stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CMP stock by insiders over the last 6 months:
- JOSEPH E REECE purchased 5,000 shares for an estimated $48,400
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Compass Minerals International Hedge Fund Activity
We have seen 98 institutional investors add shares of Compass Minerals International stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NEWTYN MANAGEMENT, LLC added 1,277,183 shares (+inf%) to their portfolio in Q2 2025, for an estimated $25,658,606
- SW INVESTMENT MANAGEMENT LLC removed 1,000,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $9,290,000
- EWING MORRIS & CO. INVESTMENT PARTNERS LTD. added 856,149 shares (+201.7%) to their portfolio in Q2 2025, for an estimated $17,200,033
- BLACKROCK, INC. removed 818,188 shares (-16.3%) from their portfolio in Q2 2025, for an estimated $16,437,396
- CASTLEKNIGHT MANAGEMENT LP removed 681,799 shares (-82.6%) from their portfolio in Q2 2025, for an estimated $13,697,341
- SAILINGSTONE CAPITAL PARTNERS LLC removed 640,675 shares (-10.3%) from their portfolio in Q2 2025, for an estimated $12,871,160
- MICHELSON MEDICAL RESEARCH FOUNDATION, INC. removed 600,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,054,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Compass Minerals International Analyst Ratings
Wall Street analysts have issued reports on $CMP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Deutsche Bank issued a "Buy" rating on 06/23/2025
To track analyst ratings and price targets for Compass Minerals International, check out Quiver Quantitative's $CMP forecast page.
Compass Minerals International Price Targets
Multiple analysts have issued price targets for $CMP recently. We have seen 3 analysts offer price targets for $CMP in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Jeffrey Zekauskas from JP Morgan set a target price of $18.0 on 08/13/2025
- David Begleiter from Deutsche Bank set a target price of $22.0 on 06/23/2025
- Joel Jackson from BMO Capital set a target price of $20.0 on 05/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Q32 Bio Inc. (QTTB) have been notably active, largely driven by the company’s upcoming participation in the 2025 Wells Fargo Healthcare Conference on September 4. Many users are focusing on the potential impact of Q32 Bio’s presentations on alopecia areata and autoimmune therapy pipelines, with some expressing optimism about future growth prospects. The biotech sector’s volatility keeps the conversation lively and speculative.
Posts on X also highlight a mix of curiosity and caution regarding QTTB’s clinical-stage developments, with some users debating the timelines for meaningful results from their pipeline. The tone of these discussions often swings between hope for breakthroughs and concern over the inherent risks of biotech investments. This ongoing dialogue reflects a broader interest in how Q32 Bio might position itself in a competitive market.
Note: This discussion summary was generated from an AI condensation of post data.
Q32 Bio Inc. Insider Trading Activity
Q32 Bio Inc. insiders have traded $QTTB stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $QTTB stock by insiders over the last 6 months:
- JODIE POPE MORRISON (CEO) sold 10,494 shares for an estimated $18,899
- LEE KALOWSKI (CFO and President) sold 4,240 shares for an estimated $7,636
- SHELIA M. VIOLETTE (Chief Scientific Officer) sold 2,990 shares for an estimated $5,384
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Q32 Bio Inc. Hedge Fund Activity
We have seen 22 institutional investors add shares of Q32 Bio Inc. stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIO CAPITAL MANAGEMENT, LLC removed 697,413 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,150,731
- TEMASEK HOLDINGS (PRIVATE) LTD removed 313,943 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $518,005
- BLACKROCK, INC. removed 278,694 shares (-60.9%) from their portfolio in Q2 2025, for an estimated $415,254
- MILLENNIUM MANAGEMENT LLC added 130,379 shares (+inf%) to their portfolio in Q2 2025, for an estimated $194,264
- STATE STREET CORP removed 110,561 shares (-80.4%) from their portfolio in Q2 2025, for an estimated $164,735
- MONACO ASSET MANAGEMENT SAM added 86,486 shares (+17.1%) to their portfolio in Q2 2025, for an estimated $128,864
- ARROWMARK COLORADO HOLDINGS LLC removed 81,482 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $134,445
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Ardelyx (ARDX) have been buzzing with activity, particularly around insider trading and upcoming legal developments. Posts on the platform highlight a significant insider sale by a top executive, sparking debates about the implications for the company's future. Many users are also focused on a pending CMS case, with some speculating that a favorable outcome could drive the stock price significantly higher.
Additionally, there’s notable chatter about Ardelyx’s product performance, with some users pointing to record-breaking script numbers as a sign of strong growth potential. Others are sharing technical chart insights and predictions for the stock’s movement in the coming months. The conversation reflects a mix of optimism and caution as investors weigh these recent developments.
Note: This discussion summary was generated from an AI condensation of post data.
Ardelyx Insider Trading Activity
Ardelyx insiders have traded $ARDX stock on the open market 21 times in the past 6 months. Of those trades, 4 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:
- DAVID M MOTT has made 4 purchases buying 881,377 shares for an estimated $3,403,196 and 0 sales.
- MICHAEL RAAB (President & CEO) has made 0 purchases and 5 sales selling 217,504 shares for an estimated $1,053,598.
- LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 4 sales selling 92,682 shares for an estimated $553,025.
- ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 17,815 shares for an estimated $101,034.
- MIKE KELLIHER (Chief Business Officer) has made 0 purchases and 2 sales selling 19,939 shares for an estimated $91,402.
- JUSTIN A RENZ (Chief Financial Officer) has made 0 purchases and 2 sales selling 14,255 shares for an estimated $71,200.
- ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,833 shares for an estimated $59,102.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Ardelyx Hedge Fund Activity
We have seen 107 institutional investors add shares of Ardelyx stock to their portfolio, and 131 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 9,919,066 shares (-39.7%) from their portfolio in Q2 2025, for an estimated $38,882,738
- EVENTIDE ASSET MANAGEMENT, LLC removed 5,600,764 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $27,499,751
- MILLENNIUM MANAGEMENT LLC added 5,197,967 shares (+80.4%) to their portfolio in Q2 2025, for an estimated $20,376,030
- MARSHALL WACE, LLP added 2,866,843 shares (+34.2%) to their portfolio in Q2 2025, for an estimated $11,238,024
- BLACKROCK, INC. added 2,799,200 shares (+15.6%) to their portfolio in Q2 2025, for an estimated $10,972,864
- BANK OF AMERICA CORP /DE/ added 2,600,080 shares (+88.8%) to their portfolio in Q2 2025, for an estimated $10,192,313
- JONES FINANCIAL COMPANIES LLLP added 1,832,320 shares (+16861.3%) to their portfolio in Q2 2025, for an estimated $7,182,694
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Ardelyx Government Contracts
We have seen $34,284 of award payments to $ARDX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- XPHOZAH: $34,284
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Ardelyx Analyst Ratings
Wall Street analysts have issued reports on $ARDX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 06/18/2025
- Citigroup issued a "Buy" rating on 05/02/2025
- Ladenburg Thalmann issued a "Buy" rating on 03/07/2025
- Scotiabank issued a "Sector Outperform" rating on 03/07/2025
To track analyst ratings and price targets for Ardelyx, check out Quiver Quantitative's $ARDX forecast page.
Ardelyx Price Targets
Multiple analysts have issued price targets for $ARDX recently. We have seen 7 analysts offer price targets for $ARDX in the last 6 months, with a median target of $11.0.
Here are some recent targets:
- Christopher Raymond from Piper Sandler set a target price of $9.0 on 08/06/2025
- Laura Chico from Wedbush set a target price of $14.0 on 08/05/2025
- Ryan Deschner from Raymond James set a target price of $12.0 on 08/05/2025
- Matthew Caufield from HC Wainwright & Co. set a target price of $10.0 on 06/18/2025
- Yigal Nochomovitz from Citigroup set a target price of $10.0 on 05/02/2025
- Louise Chen from Scotiabank set a target price of $15.0 on 03/07/2025
- Aydin Huseynov from Ladenburg Thalmann set a target price of $11.0 on 03/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Broadcom Inc. (AVGO) have been ignited by the company's strong positioning in the AI sector and positive analyst updates. Many users are captivated by the stock's recent performance, especially following news of raised price targets by major financial institutions, reflecting confidence in its growth trajectory. The buzz is further fueled by Broadcom's role in AI chip demand, particularly after encouraging earnings reports from related industry giants.
Conversations also touch on the stock's volatility, with some expressing curiosity about upcoming quarterly results and their potential impact on market momentum. There’s a keen interest in how Broadcom’s partnerships and innovations in semiconductors might shape its future, keeping the dialogue dynamic. The tone on X suggests a community closely watching for the next big development in this tech giant's story.
Note: This discussion summary was generated from an AI condensation of post data.
Broadcom Inc. Congressional Stock Trading
Members of Congress have traded $AVGO stock 34 times in the past 6 months. Of those trades, 18 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $AVGO stock by members of Congress over the last 6 months:
- REPRESENTATIVE CLEO FIELDS has traded it 2 times. They made 2 purchases worth up to $65,000 on 07/29, 07/18 and 0 sales.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/18.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/25 and 1 sale worth up to $15,000 on 03/19.
- REPRESENTATIVE NANCY PELOSI purchased up to $5,000,000 on 06/20.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/17, 06/11 and 1 sale worth up to $15,000 on 06/10.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 4 times. They made 1 purchase worth up to $15,000 on 06/11 and 3 sales worth up to $45,000 on 04/03, 03/31, 03/11.
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 2 purchases worth up to $30,000 on 06/11, 04/08 and 0 sales.
- REPRESENTATIVE DAVID TAYLOR purchased up to $15,000 on 05/14.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 03/13 and 2 sales worth up to $300,000 on 05/12, 04/17.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 3 times. They made 1 purchase worth up to $15,000 on 03/03 and 2 sales worth up to $30,000 on 04/21, 03/20.
- REPRESENTATIVE KELLY MORRISON has traded it 4 times. They made 4 purchases worth up to $95,000 on 04/11, 03/21 and 0 sales.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/20 and 0 sales.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $80,000 on 03/11, 03/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Broadcom Inc. Insider Trading Activity
Broadcom Inc. insiders have traded $AVGO stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $AVGO stock by insiders over the last 6 months:
- HENRY SAMUELI has made 0 purchases and 18 sales selling 1,137,874 shares for an estimated $246,314,400.
- HOCK E TAN (President and CEO) has made 0 purchases and 3 sales selling 197,758 shares for an estimated $51,000,815.
- MARK DAVID BRAZEAL (Chief Legal & Corp Affairs Ofc) has made 0 purchases and 4 sales selling 155,000 shares for an estimated $36,108,800.
- KIRSTEN M. SPEARS (CFO & Chief Accounting Officer) has made 0 purchases and 2 sales selling 92,660 shares for an estimated $23,673,114.
- CHARLIE B KAWWAS (President, Semi Solutions Grp) sold 10,000 shares for an estimated $2,528,810
- JUSTINE PAGE has made 0 purchases and 5 sales selling 4,000 shares for an estimated $997,840.
- GAYLA J DELLY sold 3,000 shares for an estimated $795,390
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Broadcom Inc. Hedge Fund Activity
We have seen 2,228 institutional investors add shares of Broadcom Inc. stock to their portfolio, and 1,755 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GAMMA INVESTING LLC removed 17,161,157 shares (-99.3%) from their portfolio in Q2 2025, for an estimated $4,730,472,927
- FMR LLC added 15,242,268 shares (+15.0%) to their portfolio in Q2 2025, for an estimated $4,201,531,174
- PRICE T ROWE ASSOCIATES INC /MD/ added 12,640,424 shares (+19.3%) to their portfolio in Q2 2025, for an estimated $3,484,332,875
- CAPITAL INTERNATIONAL INVESTORS removed 12,484,722 shares (-7.6%) from their portfolio in Q2 2025, for an estimated $3,441,413,619
- JANE STREET GROUP, LLC removed 7,333,469 shares (-97.8%) from their portfolio in Q2 2025, for an estimated $2,021,470,729
- CAPITAL WORLD INVESTORS removed 6,799,578 shares (-4.4%) from their portfolio in Q2 2025, for an estimated $1,874,303,675
- VANGUARD GROUP INC added 6,222,802 shares (+1.3%) to their portfolio in Q2 2025, for an estimated $1,715,315,371
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Broadcom Inc. Government Contracts
We have seen $82,540,151 of award payments to $AVGO over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- NEW 66 MONTH OPEN-MARKET CONTRACT FOR RENEWAL OF CA SOFTWARE, SUPPORT SERVICES, AND MAINTENANCE. CA PROPRIE...: $55,000,000
- CA SOFTWARE MAINTENANCE: $21,091,011
- BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $3,629,376
- BROADCOM CONTRACT: TASK ORDER FOR REPRESENTATIVE PAYEE MONITORING TOOL (RPMT) SUPPORT SERVICES.: $1,489,129
- BROADCOM TECHNICAL SUPPORT SERVICES INDEFINITE DELIVERY/INDEFINITE QUANTITY (IDIQ) CONTRACT - TASK ORDER F...: $728,962
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Broadcom Inc. Analyst Ratings
Wall Street analysts have issued reports on $AVGO in the last several months. We have seen 18 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 08/28/2025
- Goldman Sachs issued a "Buy" rating on 08/13/2025
- Morgan Stanley issued a "Overweight" rating on 07/30/2025
- Mizuho issued a "Outperform" rating on 07/03/2025
- Barclays issued a "Overweight" rating on 06/09/2025
- Citigroup issued a "Buy" rating on 06/09/2025
- UBS issued a "Buy" rating on 06/06/2025
To track analyst ratings and price targets for Broadcom Inc., check out Quiver Quantitative's $AVGO forecast page.
Broadcom Inc. Price Targets
Multiple analysts have issued price targets for $AVGO recently. We have seen 21 analysts offer price targets for $AVGO in the last 6 months, with a median target of $315.0.
Here are some recent targets:
- Rick Schafer from Oppenheimer set a target price of $325.0 on 08/28/2025
- Timothy Arcuri from UBS set a target price of $345.0 on 08/25/2025
- Harsh Kumar from Piper Sandler set a target price of $315.0 on 08/22/2025
- James Schneider from Goldman Sachs set a target price of $340.0 on 08/13/2025
- Joseph Moore from Morgan Stanley set a target price of $338.0 on 07/30/2025
- Vijay Rakesh from Mizuho set a target price of $320.0 on 07/16/2025
- John Vinh from Keybanc set a target price of $330.0 on 07/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Ichor Holdings (ICHR) have been ignited by the company’s Q2 2025 earnings report, which has drawn significant attention from investors and analysts alike. Many users on the platform have pointed out the mixed signals from the report, with some expressing concern over operational challenges and analyst downgrades that followed. The conversation remains lively, as participants debate the implications of lowered price targets by several firms.
Adding to the intensity, posts on X have also highlighted the semiconductor industry dynamics affecting Ichor, with some linking the company’s performance to its key customers’ activities. There’s a split in opinions, with a few voices showing optimism about potential growth tied to industry trends, while others remain cautious due to recent stock price declines. This ongoing dialogue keeps the ticker at the forefront of market watchers’ minds.
Note: This discussion summary was generated from an AI condensation of post data.
Ichor Holdings Congressional Stock Trading
Members of Congress have traded $ICHR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ICHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE DEBBIE WASSERMAN SCHULTZ purchased up to $15,000 on 08/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Ichor Holdings Insider Trading Activity
Ichor Holdings insiders have traded $ICHR stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ICHR stock by insiders over the last 6 months:
- IAIN MACKENZIE purchased 25,000 shares for an estimated $415,750
- JEFF ANDRESON (Chief Executive Officer) purchased 10,000 shares for an estimated $168,600
- MARC HAUGEN has made 2 purchases buying 6,000 shares for an estimated $106,170 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Ichor Holdings Hedge Fund Activity
We have seen 98 institutional investors add shares of Ichor Holdings stock to their portfolio, and 114 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 792,879 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $17,926,994
- NUVEEN, LLC removed 540,145 shares (-89.0%) from their portfolio in Q2 2025, for an estimated $10,608,447
- INVESCO LTD. removed 394,251 shares (-33.7%) from their portfolio in Q2 2025, for an estimated $7,743,089
- OBERWEIS ASSET MANAGEMENT INC/ removed 337,800 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,634,392
- ROYCE & ASSOCIATES LP added 315,013 shares (+33.8%) to their portfolio in Q2 2025, for an estimated $6,186,855
- BANK OF NEW YORK MELLON CORP added 304,228 shares (+143.9%) to their portfolio in Q2 2025, for an estimated $5,975,037
- BARROW HANLEY MEWHINNEY & STRAUSS LLC added 284,369 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,585,007
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Ichor Holdings Analyst Ratings
Wall Street analysts have issued reports on $ICHR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 08/06/2025
- Stifel issued a "Buy" rating on 08/05/2025
- B. Riley Securities issued a "Buy" rating on 07/11/2025
To track analyst ratings and price targets for Ichor Holdings, check out Quiver Quantitative's $ICHR forecast page.
Ichor Holdings Price Targets
Multiple analysts have issued price targets for $ICHR recently. We have seen 4 analysts offer price targets for $ICHR in the last 6 months, with a median target of $26.5.
Here are some recent targets:
- Thomas Diffely from DA Davidson set a target price of $35.0 on 08/06/2025
- Brian Chin from Stifel set a target price of $23.0 on 08/05/2025
- Edward Yang from Oppenheimer set a target price of $21.0 on 08/05/2025
- Craig Ellis from B. Riley Securities set a target price of $30.0 on 07/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Novo Nordisk (NVO) have been ignited by the company's disappointing Q2 earnings and a significant cut in its full-year 2025 sales growth forecast. Many users are expressing concern over weakening demand for Wegovy in the U.S. market, compounded by fierce competition from rival weight-loss drugs. The stock's sharp decline, with some noting drops of up to 31% in a single day, has fueled intense debates about future prospects.
Additionally, the FDA approval of Wegovy for treating metabolic-associated steatohepatitis (MASH), a serious liver disease, has sparked a mix of intrigue and optimism among some on the platform. There’s curiosity about whether this development could offset recent setbacks and bolster the company’s position in the obesity care market. The conversation remains dynamic as investors weigh both the challenges and potential catalysts ahead.
Note: This discussion summary was generated from an AI condensation of post data.
Novo Nordisk Congressional Stock Trading
Members of Congress have traded $NVO stock 12 times in the past 6 months. Of those trades, 8 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $NVO stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 08/19.
- REPRESENTATIVE SCOTT FRANKLIN has traded it 6 times. They made 6 purchases worth up to $160,000 on 08/04, 03/27 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/09 and 1 sale worth up to $15,000 on 07/10.
- REPRESENTATIVE LAUREL M. LEE sold up to $15,000 on 05/08.
- REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 03/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Novo Nordisk Hedge Fund Activity
We have seen 688 institutional investors add shares of Novo Nordisk stock to their portfolio, and 959 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 10,001,898 shares (+301443.6%) to their portfolio in Q2 2025, for an estimated $690,330,999
- AMUNDI removed 4,938,507 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $340,855,753
- FMR LLC added 4,308,228 shares (+44.7%) to their portfolio in Q2 2025, for an estimated $297,353,896
- TWO SIGMA ADVISERS, LP removed 3,465,100 shares (-71.3%) from their portfolio in Q2 2025, for an estimated $239,161,202
- NUVEEN, LLC removed 3,236,504 shares (-60.7%) from their portfolio in Q2 2025, for an estimated $223,383,506
- D. E. SHAW & CO., INC. removed 2,582,572 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $178,249,119
- JPMORGAN CHASE & CO removed 2,169,545 shares (-39.5%) from their portfolio in Q2 2025, for an estimated $149,741,995
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Novo Nordisk Analyst Ratings
Wall Street analysts have issued reports on $NVO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- TD Cowen issued a "Buy" rating on 08/19/2025
To track analyst ratings and price targets for Novo Nordisk, check out Quiver Quantitative's $NVO forecast page.
Novo Nordisk Price Targets
Multiple analysts have issued price targets for $NVO recently. We have seen 2 analysts offer price targets for $NVO in the last 6 months, with a median target of $67.0.
Here are some recent targets:
- Michael Nedelcovych from TD Cowen set a target price of $70.0 on 08/19/2025
- Evan David Seigerman from BMO Capital set a target price of $64.0 on 04/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Affirm Holdings (AFRM) have been buzzing with excitement following the company's record-breaking fourth-quarter results for fiscal 2025. Posts highlight a significant surge in stock price, with revenue growth exceeding expectations and gross merchandise volume showing robust increases. Many users are pointing to strong execution and optimistic guidance as key drivers of the momentum.
The conversation also reflects on analyst upgrades, with several price target increases noted across the platform, fueling further interest in the buy-now-pay-later leader. Some users express confidence in the company's growth trajectory, citing secular adoption and expanding partnerships. However, there are whispers of caution regarding potential volatility as the stock nears recent highs.
Note: This discussion summary was generated from an AI condensation of post data.
Affirm Holdings Insider Trading Activity
Affirm Holdings insiders have traded $AFRM stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $AFRM stock by insiders over the last 6 months:
- MICHAEL LINFORD (Chief Operating Officer) has made 0 purchases and 2 sales selling 195,000 shares for an estimated $15,616,578.
- MAX R LEVCHIN (Chief Executive Officer) has made 0 purchases and 2 sales selling 182,396 shares for an estimated $14,609,171.
- KATHERINE ADKINS (Chief Legal Officer) has made 0 purchases and 4 sales selling 124,187 shares for an estimated $9,045,117.
- ROBERT O'HARE (Chief Financial Officer) has made 0 purchases and 3 sales selling 109,007 shares for an estimated $8,530,136.
- KEITH RABOIS has made 0 purchases and 11 sales selling 48,265 shares for an estimated $2,580,200.
- SIPHELELE JIYANE (Chief Accounting Officer) sold 15,871 shares for an estimated $1,190,325
- NOEL BERTRAM WATSON has made 0 purchases and 7 sales selling 5,000 shares for an estimated $266,597.
- CHRISTA S QUARLES sold 754 shares for an estimated $50,842
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Affirm Holdings Hedge Fund Activity
We have seen 337 institutional investors add shares of Affirm Holdings stock to their portfolio, and 276 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- COATUE MANAGEMENT LLC removed 2,633,442 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $119,005,243
- CITADEL ADVISORS LLC removed 2,526,577 shares (-94.4%) from their portfolio in Q2 2025, for an estimated $174,687,533
- BLACKROCK, INC. added 2,423,821 shares (+18.3%) to their portfolio in Q2 2025, for an estimated $167,582,983
- ATREIDES MANAGEMENT, LP added 1,670,429 shares (+543.3%) to their portfolio in Q2 2025, for an estimated $115,493,461
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,644,545 shares (-56.4%) from their portfolio in Q2 2025, for an estimated $113,703,841
- HOLOCENE ADVISORS, LP removed 1,595,879 shares (-63.9%) from their portfolio in Q2 2025, for an estimated $110,339,074
- BAILLIE GIFFORD & CO removed 1,471,061 shares (-16.3%) from their portfolio in Q2 2025, for an estimated $101,709,157
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Affirm Holdings Analyst Ratings
Wall Street analysts have issued reports on $AFRM in the last several months. We have seen 15 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 08/29/2025
- B of A Securities issued a "Buy" rating on 08/29/2025
- Evercore ISI Group issued a "Outperform" rating on 08/29/2025
- Jefferies issued a "Buy" rating on 08/26/2025
- JP Morgan issued a "Overweight" rating on 08/20/2025
- Susquehanna issued a "Positive" rating on 07/23/2025
- Oppenheimer issued a "Outperform" rating on 07/21/2025
To track analyst ratings and price targets for Affirm Holdings, check out Quiver Quantitative's $AFRM forecast page.
Affirm Holdings Price Targets
Multiple analysts have issued price targets for $AFRM recently. We have seen 20 analysts offer price targets for $AFRM in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- Timothy Chiodo from UBS set a target price of $85.0 on 08/29/2025
- Jason Kupferberg from B of A Securities set a target price of $94.0 on 08/29/2025
- Adam Frisch from Evercore ISI Group set a target price of $100.0 on 08/29/2025
- James Faucette from Morgan Stanley set a target price of $90.0 on 08/29/2025
- David M. Scharf from JMP Securities set a target price of $105.0 on 08/29/2025
- John Hecht from Jefferies set a target price of $95.0 on 08/26/2025
- Reginald Smith from JP Morgan set a target price of $91.0 on 08/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent chatter on X regarding East West Bancorp (EWBC) has been notably active, with much of the focus on the company’s latest financial performance and strategic moves. Many discussions highlight the bank’s impressive growth and profitability, often attributing success to its specialized role in bridging U.S.-Asia banking markets. There’s also curiosity around its upcoming presentation at a major financial services conference, with speculation about potential positive announcements.
Additionally, posts on X have touched on recent insider activity, specifically a director’s sale of shares, which has sparked varied reactions among users. Some see it as a routine transaction, while others question the timing and its implications for the stock’s future. The conversation remains dynamic, reflecting a mix of optimism and scrutiny surrounding the bank’s trajectory.
Note: This discussion summary was generated from an AI condensation of post data.
East West Bancorp Insider Trading Activity
East West Bancorp insiders have traded $EWBC stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $EWBC stock by insiders over the last 6 months:
- DOMINIC NG (Chief Executive Officer) has made 0 purchases and 6 sales selling 120,000 shares for an estimated $11,592,720.
- IRENE H OH (Chief Risk Officer) has made 0 purchases and 2 sales selling 15,051 shares for an estimated $1,606,403.
- GARY TEO (Executive Vice President) has made 0 purchases and 2 sales selling 6,550 shares for an estimated $697,376.
- LISA L. KIM (Executive Vice President) sold 2,100 shares for an estimated $199,584
- JACK C LIU sold 1,000 shares for an estimated $105,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
East West Bancorp Hedge Fund Activity
We have seen 258 institutional investors add shares of East West Bancorp stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. added 2,968,716 shares (+38.5%) to their portfolio in Q2 2025, for an estimated $299,780,941
- BOSTON PARTNERS added 920,159 shares (+39.6%) to their portfolio in Q2 2025, for an estimated $92,917,655
- SEI INVESTMENTS CO added 687,145 shares (+448.5%) to their portfolio in Q2 2025, for an estimated $69,387,902
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 554,177 shares (-13.8%) from their portfolio in Q2 2025, for an estimated $55,960,793
- AQR CAPITAL MANAGEMENT LLC added 542,149 shares (+61.9%) to their portfolio in Q2 2025, for an estimated $54,746,206
- FMR LLC added 523,510 shares (+7.1%) to their portfolio in Q2 2025, for an estimated $52,864,039
- LORD, ABBETT & CO. LLC removed 502,649 shares (-45.9%) from their portfolio in Q2 2025, for an estimated $50,757,496
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
East West Bancorp Analyst Ratings
Wall Street analysts have issued reports on $EWBC in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 07/08/2025
- Citigroup issued a "Buy" rating on 07/02/2025
- Jefferies issued a "Buy" rating on 05/21/2025
- DA Davidson issued a "Buy" rating on 04/23/2025
- Wells Fargo issued a "Overweight" rating on 04/09/2025
To track analyst ratings and price targets for East West Bancorp, check out Quiver Quantitative's $EWBC forecast page.
East West Bancorp Price Targets
Multiple analysts have issued price targets for $EWBC recently. We have seen 8 analysts offer price targets for $EWBC in the last 6 months, with a median target of $118.0.
Here are some recent targets:
- Christopher Mcgratty from Keefe, Bruyette & Woods set a target price of $120.0 on 07/23/2025
- Gary Tenner from DA Davidson set a target price of $125.0 on 07/23/2025
- Brandon King from Truist Securities set a target price of $110.0 on 07/11/2025
- Timur Braziler from Wells Fargo set a target price of $125.0 on 07/10/2025
- Jared Shaw from Barclays set a target price of $135.0 on 07/08/2025
- Benjamin Gerlinger from Citigroup set a target price of $116.0 on 07/02/2025
- David Chiaverini from Jefferies set a target price of $115.0 on 05/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent discussions on X about Tempus AI, Inc. (TEM) have been lively, largely driven by the company’s latest earnings report and an optimistic financial outlook for 2025. Many users are highlighting the significant revenue growth and reduced net loss as key positives, sparking debates about the stock’s future trajectory. The conversation often centers on whether these financial improvements signal sustained momentum for the healthcare AI firm.
Additionally, there’s a mix of technical analysis and speculation circulating on the platform, with some focusing on recent price movements and potential breakout levels. A few posts have also brought attention to challenges, such as past short reports questioning the company’s AI-driven revenue, though optimism seems to dominate. The buzz around TEM reflects a broader interest in how AI innovations might shape the healthcare sector.
Note: This discussion summary was generated from an AI condensation of post data.
Tempus AI, Inc. Insider Trading Activity
Tempus AI, Inc. insiders have traded $TEM stock on the open market 139 times in the past 6 months. Of those trades, 0 have been purchases and 139 have been sales.
Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:
- ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 44 sales selling 1,512,805 shares for an estimated $88,789,479.
- RYAN FUKUSHIMA (Chief Operating Officer) has made 0 purchases and 18 sales selling 90,280 shares for an estimated $5,413,740.
- THEODORE LEONSIS has made 0 purchases and 3 sales selling 64,770 shares for an estimated $4,643,220.
- ERIK PHELPS (EVP & Chief Admin & Legal Off) has made 0 purchases and 8 sales selling 63,396 shares for an estimated $4,529,084.
- JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 12 sales selling 53,679 shares for an estimated $3,083,502.
- SCOTT GOTTLIEB has made 0 purchases and 9 sales selling 55,675 shares for an estimated $2,674,142.
- ANDREW POLOVIN (EVP and General Counsel) has made 0 purchases and 13 sales selling 40,584 shares for an estimated $2,376,777.
- WAYNE A.I. FREDERICK has made 0 purchases and 6 sales selling 12,000 shares for an estimated $576,278.
- RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 5 sales selling 7,977 shares for an estimated $526,163.
- JENNIFER A DOUDNA has made 0 purchases and 7 sales selling 10,491 shares for an estimated $524,086.
- NADJA WEST has made 0 purchases and 10 sales selling 8,443 shares for an estimated $414,309.
- DAVID R EPSTEIN has made 0 purchases and 4 sales selling 1,980 shares for an estimated $100,365.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Tempus AI, Inc. Government Contracts
We have seen $5,785,617 of award payments to $TEM over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- TUMOR NORMAL MATCHED GENOMIC TESTING SERVICES: $5,718,045
- DNA METHYLATION SERVICES FOR TELECONFERENCING EXERCISE STUDY IN HIV + PATIENTS: $67,572
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Tempus AI, Inc. Analyst Ratings
Wall Street analysts have issued reports on $TEM in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 08/20/2025
- Morgan Stanley issued a "Overweight" rating on 08/12/2025
- Guggenheim issued a "Buy" rating on 06/30/2025
- Needham issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for Tempus AI, Inc., check out Quiver Quantitative's $TEM forecast page.
Tempus AI, Inc. Price Targets
Multiple analysts have issued price targets for $TEM recently. We have seen 6 analysts offer price targets for $TEM in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $85.0 on 08/20/2025
- Tejas Savant from Morgan Stanley set a target price of $68.0 on 08/12/2025
- Subbu Nambi from Guggenheim set a target price of $75.0 on 06/30/2025
- Michael Ryskin from B of A Securities set a target price of $70.0 on 06/25/2025
- David Westenberg from Piper Sandler set a target price of $70.0 on 05/15/2025
- Ryan MacDonald from Needham set a target price of $70.0 on 05/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Recent chatter on X about UnitedHealth Group (UNH) has been dominated by the ongoing Department of Justice investigation into the company’s Medicare billing practices and broader regulatory scrutiny. Many users are expressing deep concern over the potential financial repercussions, pointing to the stock’s steep 40% year-to-date decline as a sign of mounting pressure. The intensity of these discussions underscores a growing unease about the company’s near-term outlook.
Amidst the regulatory storm, some on X have noted a glimmer of hope with reports of significant investment stakes by prominent figures, suggesting a potential vote of confidence in UNH’s long-term prospects. Conversations also touch on the company’s recent leadership changes and suspended 2025 financial outlook, fueling debates about whether the stock has hit a bottom or faces further challenges. This mix of worry and cautious optimism keeps the dialogue dynamic and highly engaged.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 32 times in the past 6 months. Of those trades, 14 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 3 times. They made 3 purchases worth up to $80,000 on 08/04, 05/16, 05/14 and 0 sales.
- SENATOR MARKWAYNE MULLIN sold up to $50,000 on 08/01.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 07/24, 04/07.
- REPRESENTATIVE TIM MOORE has traded it 2 times. They made 2 purchases worth up to $65,000 on 07/21, 07/16 and 0 sales.
- SENATOR ANGUS S. KING JR. sold up to $15,000 on 07/15.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/17 and 1 sale worth up to $15,000 on 06/24.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 06/23.
- SENATOR JOHN BOOZMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/16 and 1 sale worth up to $15,000 on 06/11.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $65,000 on 05/30, 03/31 and 1 sale worth up to $15,000 on 04/29.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 05/15.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $50,000 on 04/08 and 1 sale worth up to $50,000 on 05/15.
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 05/14.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 2 purchases worth up to $100,000 on 04/07, 03/31 and 1 sale worth up to $50,000 on 05/08.
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 04/11.
- REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 04/10.
- REPRESENTATIVE GREG LANDSMAN sold up to $50,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
UnitedHealth Group Insider Trading Activity
UnitedHealth Group insiders have traded $UNH stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $UNH stock by insiders over the last 6 months:
- STEPHEN J HEMSLEY (CEO, UHG) purchased 86,700 shares for an estimated $25,019,019
- JOHN F REX (President & CFO) purchased 17,175 shares for an estimated $4,999,919
- KRISTEN GIL purchased 3,700 shares for an estimated $1,003,329
- TIMOTHY PATRICK FLYNN purchased 1,533 shares for an estimated $491,786
- PATRICK HUGH CONWAY (Chief Executive Officer, Optum) sold 589 shares for an estimated $179,645
- JOHN H NOSEWORTHY purchased 300 shares for an estimated $93,646
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
UnitedHealth Group Hedge Fund Activity
We have seen 1,521 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 2,240 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 15,078,082 shares (-72.4%) from their portfolio in Q2 2025, for an estimated $4,703,909,241
- GAMMA INVESTING LLC removed 8,283,184 shares (-99.9%) from their portfolio in Q2 2025, for an estimated $2,584,104,912
- FMR LLC removed 7,414,111 shares (-30.6%) from their portfolio in Q2 2025, for an estimated $2,312,980,208
- JPMORGAN CHASE & CO removed 6,297,614 shares (-24.0%) from their portfolio in Q2 2025, for an estimated $1,964,666,639
- MORGAN STANLEY removed 6,262,215 shares (-29.3%) from their portfolio in Q2 2025, for an estimated $1,953,623,213
- BERKSHIRE HATHAWAY INC added 5,039,564 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,572,192,781
- DODGE & COX added 4,730,192 shares (+117.7%) to their portfolio in Q2 2025, for an estimated $1,475,677,998
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
UnitedHealth Group Government Contracts
We have seen $19,929,729,268 of award payments to $UNH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: R3 FY25 3RD QTR APRIL: $830,362,703
- EXPRESS REPORT: R3 FY25 3RD QTR MAY: $819,320,444
- EXPRESS REPORT: R3 FY25 2ND QTR MARCH: $791,841,212
- EXPRESS REPORT: R3 FY25 1ST QTR OCTOBER: $771,731,035
- EXPRESS REPORT: R3 FY25 1ST QTR NOVEMBER: $749,361,473
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
UnitedHealth Group Analyst Ratings
Wall Street analysts have issued reports on $UNH in the last several months. We have seen 15 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 08/26/2025
- Morgan Stanley issued a "Overweight" rating on 08/20/2025
- JP Morgan issued a "Overweight" rating on 08/06/2025
- Baird issued a "Underperform" rating on 07/31/2025
- Keybanc issued a "Overweight" rating on 07/30/2025
- RBC Capital issued a "Outperform" rating on 07/30/2025
- Oppenheimer issued a "Outperform" rating on 07/30/2025
To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 20 analysts offer price targets for $UNH in the last 6 months, with a median target of $331.0.
Here are some recent targets:
- Sarah James from Cantor Fitzgerald set a target price of $440.0 on 08/26/2025
- Ricky Goldwasser from Morgan Stanley set a target price of $325.0 on 08/20/2025
- Kevin Fischbeck from B of A Securities set a target price of $325.0 on 08/18/2025
- Lisa Gill from JP Morgan set a target price of $310.0 on 08/06/2025
- Stephen Baxter from Wells Fargo set a target price of $267.0 on 08/04/2025
- Michael Ha from Baird set a target price of $198.0 on 07/31/2025
- Matthew Gillmor from Keybanc set a target price of $350.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Xavier Urbain, a director at $LKQ, bought 15,000 shares of the company on 08-28-2025 for an estimated $481,756. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 80.3%. Following this trade, they now own 33,669 shares of this class of $LKQ stock.
$LKQ Insider Trading Activity
$LKQ insiders have traded $LKQ stock on the open market 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $LKQ stock by insiders over the last 6 months:
- DOMINICK P ZARCONE has made 0 purchases and 3 sales selling 35,000 shares for an estimated $1,457,227.
- XAVIER URBAIN purchased 15,000 shares for an estimated $481,756
- JUSTIN L JUDE (President and CEO) has made 2 purchases buying 8,377 shares for an estimated $278,751 and 0 sales.
- ANDREW C CLARKE purchased 5,000 shares for an estimated $159,773
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LKQ Hedge Fund Activity
We have seen 323 institutional investors add shares of $LKQ stock to their portfolio, and 389 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- LYRICAL ASSET MANAGEMENT LP added 3,086,967 shares (+inf%) to their portfolio in Q2 2025, for an estimated $114,248,648
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 2,741,220 shares (+inf%) to their portfolio in Q2 2025, for an estimated $101,452,552
- EMINENCE CAPITAL, LP removed 1,876,031 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $79,806,358
- PZENA INVESTMENT MANAGEMENT LLC added 1,779,315 shares (+176.9%) to their portfolio in Q2 2025, for an estimated $65,852,448
- RIVER ROAD ASSET MANAGEMENT, LLC removed 1,575,181 shares (-46.1%) from their portfolio in Q2 2025, for an estimated $58,297,448
- SWEDBANK AB added 1,290,053 shares (+58.2%) to their portfolio in Q2 2025, for an estimated $47,744,861
- ENGINE CAPITAL MANAGEMENT, LP removed 1,266,614 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $46,877,384
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LKQ Analyst Ratings
Wall Street analysts have issued reports on $LKQ in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 07/25/2025
- Barrington Research issued a "Outperform" rating on 07/22/2025
To track analyst ratings and price targets for $LKQ, check out Quiver Quantitative's $LKQ forecast page.
$LKQ Price Targets
Multiple analysts have issued price targets for $LKQ recently. We have seen 2 analysts offer price targets for $LKQ in the last 6 months, with a median target of $51.0.
Here are some recent targets:
- Craig Kennison from Baird set a target price of $42.0 on 07/25/2025
- Gary Prestopino from Barrington Research set a target price of $60.0 on 07/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.